{"id":43345,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/class-a-common-stock-purchase-agreement-edison-schools-inc.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"class-a-common-stock-purchase-agreement-edison-schools-inc","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/class-a-common-stock-purchase-agreement-edison-schools-inc.html","title":{"rendered":"Class A Common Stock Purchase Agreement &#8211; Edison Schools Inc."},"content":{"rendered":"<pre>     ---------------------------------------------------------------------\n\n\n\n\n\n\n\n\n\n\n\n                               EDISON SCHOOLS INC.\n                            (a Delaware corporation)\n\n\n                    5,000,000 Shares of Class A Common Stock\n\n\n\n\n\n                               PURCHASE AGREEMENT\n\n\n\n\n\n\n\n\n\n\n\n      Dated: August -, 2000\n\n\n     ---------------------------------------------------------------------\n   2\n                                TABLE OF CONTENTS\n\n<\/pre>\n<table>\n<caption>\n                                                                                    PAGE<br \/>\n<s>                                                                                 <c><br \/>\nPURCHASE AGREEMENT&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   1<\/p>\n<p>SECTION 1.  Representations and Warranties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   3<br \/>\n(a)         Representations and Warranties by the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   3<br \/>\n            (i)      Compliance with Registration Requirements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   3<br \/>\n            (ii)     Independent Accountants  &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   4<br \/>\n            (iii)    Financial Statements     &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   4<br \/>\n            (iv)     No Material Adverse Change in Business&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   4<br \/>\n            (v)      Good Standing of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   5<br \/>\n            (vi)     No Subsidiaries          &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   5<br \/>\n            (vii)    Capitalization           &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   5<br \/>\n            (viii)   Authorization of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   5<br \/>\n            (ix)     Authorization and Description of Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   6<br \/>\n            (x)      Absence of Defaults and Conflicts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   6<br \/>\n            (xi)     Absence of Labor Dispute &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   7<br \/>\n            (xii)    Absence of Proceedings   &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   7<br \/>\n            (xiii)   Accuracy of Exhibits     &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   7<br \/>\n            (xiv)    Possession of Intellectual Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   7<br \/>\n            (xv)     Absence of Further Requirements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   8<br \/>\n            (xvi)    Possession of Licenses and Permits&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   8<br \/>\n            (xvii)   Compliance with Statutes, Rules and Regulations, etc&#8230;&#8230;&#8230;   9<br \/>\n            (xviii)  Title to Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   9<br \/>\n            (xix)    Investment Company Act   &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  10<br \/>\n            (xx)     Environmental Laws       &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  10<br \/>\n            (xxi)    Registration Rights      &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  11<br \/>\n            (xxii)   Apex Online Learning Inc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  11<br \/>\n            (xxiii)  Management Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  11<br \/>\n            (xxiv)   Insurance   &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  11<br \/>\n            (xxv)    Tax Returns and Payment of Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  12<br \/>\n            (xxvi)   No Stabilization or Manipulation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  12<br \/>\n            (xxvii)  Certain Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  12<br \/>\n            (xxviii) Statistical and Market Data&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  13<br \/>\n            (xxix)   Accounting and other Controls&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  13<br \/>\n(b)         Representations and Warranties by the Selling Shareholders&#8230;&#8230;&#8230;&#8230;  13<br \/>\n            (i)      Accurate Disclosure      &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  13<br \/>\n            (ii)     Authorization of Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  13<br \/>\n            (iii)    Valid and Marketable Title&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  14<br \/>\n            (iv)     Due Execution of Power of Attorney and Custody<br \/>\n                     Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  14<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       i<br \/>\n   3<\/p>\n<table>\n<s>                                                                                  <c><br \/>\n          (v)       Absence of Manipulation  &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     15<br \/>\n          (vi)      Absence of Further Requirements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     15<br \/>\n          (vii)     Restriction on Sale of Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     15<br \/>\n          (viii)    Certificates Suitable for Transfer&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     15<br \/>\n          (ix)      No Association with NASD &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     16<br \/>\n     (c)  Officer&#8217;s Certificates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     16<\/p>\n<p>SECTION 2.  Sale and Delivery to Underwriters; Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     16<br \/>\n     (a)    Initial Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     16<br \/>\n     (b)    Option Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     16<br \/>\n     (c)    Payment &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     17<br \/>\n     (d)    Denominations; Registration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     18<\/p>\n<p>SECTION 3.  Covenants of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     18<br \/>\n     (a)    Compliance with Securities Regulations and Commission Requests&#8230;&#8230;     18<br \/>\n     (b)    Filing of Amendments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     19<br \/>\n     (c)    Delivery of Registration Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     19<br \/>\n     (d)    Delivery of Prospectus&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     19<br \/>\n     (e)    Continued Compliance with Securities Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     19<br \/>\n     (f)    Blue Sky Qualifications&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     20<br \/>\n     (g)    Rule 158 &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     20<br \/>\n     (h)    Use of Proceeds&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     20<br \/>\n     (i)    Listing &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     20<br \/>\n     (j)    Restriction on Sale of Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     21<br \/>\n     (k)    Reporting Requirements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     21<\/p>\n<p>SECTION 4.  Payment of Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     21<br \/>\n     (a)    Expenses &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     21<br \/>\n     (b)    Expenses of the Selling Shareholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     22<br \/>\n     (c)    Termination of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     22<br \/>\n     (d)    Allocation of Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     22<\/p>\n<p>SECTION 5.  Conditions of Underwriters&#8217; Obligations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     22<br \/>\n     (a)    Effectiveness of Registration Statement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     23<br \/>\n     (b)    Opinion of Counsel for Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     23<br \/>\n     (c)    Opinion of Counsel for the Selling Shareholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     23<br \/>\n     (d)    Opinion of Counsel for Underwriters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     24<br \/>\n     (e)    Officers&#8217; Certificate&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     24<br \/>\n     (f)    Certificate of the Selling Shareholder&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     24<br \/>\n     (g)    Accountant&#8217;s Comfort Letter&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     24<br \/>\n     (h)    Bring-down Comfort Letter&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     25<br \/>\n     (i)    Approval of Listing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     25<br \/>\n     (j)    No Objection &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     25<br \/>\n<\/c><\/s><\/table>\n<p>                                       ii<br \/>\n   4<\/p>\n<table>\n<s>                                                                                  <c><br \/>\n     (k)    Lock-up Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     25<br \/>\n     (l)    Form W-8 or W-9&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     25<br \/>\n     (m)    Conditions to Purchase of Option Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     25<br \/>\n     (n)    Additional Documents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     26<br \/>\n     (o)    Termination of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     26<\/p>\n<p>SECTION 6.  Indemnification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     27<br \/>\n     (a)    Indemnification of Underwriters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     27<br \/>\n     (b)    Indemnification of Company, Directors and Officers and<br \/>\n            Selling Shareholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     29<br \/>\n     (c)    Actions against Parties; Notification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     29<br \/>\n     (d)    Settlement without Consent if Failure to Reimburse&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     30<br \/>\n     (e)    Other Agreements with Respect to Indemnification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     30<\/p>\n<p>SECTION 7.  Contribution&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     30<\/p>\n<p>SECTION 8.  Representations, Warranties and Agreements to Survive Delivery&#8230;&#8230;     32<\/p>\n<p>SECTION 9.  Termination of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     32<br \/>\n     (a)    Termination; General&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     32<br \/>\n     (b)    Liabilities  &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     32<\/p>\n<p>SECTION 10. Default by One or More of the Underwriters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     33<\/p>\n<p>SECTION 11. Default by One or More of the Selling Shareholders or the<br \/>\n            Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     33<\/p>\n<p>SECTION 12. Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     34<\/p>\n<p>SECTION 13. Parties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     34<\/p>\n<p>SECTION 14. GOVERNING LAW AND TIME&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     35<\/p>\n<p>SECTION 15. Effect of Headings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     35<br \/>\n<\/c><\/s><\/table>\n<p>                                      iii<br \/>\n   5<\/p>\n<table>\n<s>                                                                         <c><br \/>\nSCHEDULES<br \/>\n         Schedule A     &#8211;  List of Underwriters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     Sch A-1<br \/>\n         Schedule B     &#8211;  List of Selling Shareholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     Sch B-1<br \/>\n         Schedule C     &#8211;  Pricing Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     Sch C-1<br \/>\n         Schedule D     &#8211;  List of Persons subject to Lock-up&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     Sch D-1<br \/>\n         Schedule E     &#8211;  List of Management Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;     Sch E-1<\/p>\n<p>EXHIBITS<br \/>\n         Exhibit A-1    &#8211;  Form of Opinion of Company&#8217;s Counsel&#8230;&#8230;&#8230;&#8230;&#8230;..     A-1-1<br \/>\n         Exhibit A-2    &#8211;  Form of Opinion of Company&#8217;s<br \/>\n                           General Counsel&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     A-2-1<br \/>\n         Exhibit A-3    &#8211;  Form of Opinion of Selling<br \/>\n                           Shareholders&#8217; Counsel&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..     A-3-1<br \/>\n         Exhibit B      &#8211;  Form of Lock-up Letter&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.     B-1<br \/>\n<\/c><\/s><\/table>\n<p>                                       iv<br \/>\n   6<br \/>\n                               EDISON SCHOOLS INC.<br \/>\n                            (a Delaware corporation)<\/p>\n<p>                    5,000,000 Shares of Class A Common Stock<\/p>\n<p>                           (Par Value $.01 Per Share)<\/p>\n<p>                               PURCHASE AGREEMENT<\/p>\n<p>                                                                  August -, 2000<\/p>\n<p>MERRILL LYNCH &amp; CO.<br \/>\nMerrill Lynch, Pierce, Fenner &amp; Smith<br \/>\n       Incorporated<br \/>\nBanc of America Securities LLC<br \/>\nCredit Suisse First Boston Corporation<br \/>\nDonaldson, Lufkin &amp; Jenrette Securities Corporation<br \/>\nJ.P. Morgan Securities Inc.<br \/>\n  as Representatives of the several Underwriters<br \/>\nc\/o  Merrill Lynch &amp; Co.<br \/>\n   Merrill Lynch, Pierce, Fenner &amp; Smith<br \/>\n          Incorporated<br \/>\nNorth Tower<br \/>\nWorld Financial Center<br \/>\nNew York, New York  10281-1209<\/p>\n<p>Ladies and Gentlemen:<\/p>\n<p>         Edison Schools Inc., a Delaware corporation (the &#8220;Company&#8221;), and the<br \/>\npersons listed in Schedule B hereto (the &#8220;Selling Shareholders&#8221;) confirm their<br \/>\nrespective agreements with Merrill Lynch &amp; Co., Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated (&#8220;Merrill Lynch&#8221;) and each of the other Underwriters named in<br \/>\nSchedule A hereto (collectively, the &#8220;Underwriters&#8221;, which term shall also<br \/>\ninclude any underwriter substituted as hereinafter provided in Section 10<br \/>\nhereof), for whom Merrill Lynch, Banc of America Securities LLC, Credit Suisse<br \/>\nFirst Boston Corporation, Donaldson, Lufkin &amp; Jenrette Securities Corporation<br \/>\nand J.P. Morgan Securities Inc. are acting as representatives (in such capacity,<br \/>\nthe &#8220;Representatives&#8221;), with respect to the issue and sale by the Company and<br \/>\nthe sale by the Selling Shareholders, acting severally and not jointly, and the<br \/>\npurchase by the Underwriters, acting severally and not jointly, of the<br \/>\nrespective numbers of shares of class A common stock, par value $.01 per share,<br \/>\nof the Company (&#8220;Common Stock&#8221;) set forth in said Schedules A<br \/>\n   7<br \/>\nand B hereof, and with respect to the grant by the Company and the Selling<br \/>\nShareholders to the Underwriters, acting severally and not jointly, of the<br \/>\noption described in Section 2(b) hereof to purchase all or any part of 750,000<br \/>\nadditional shares of Common Stock to cover over-allotments, if any. The<br \/>\naforesaid 5,000,000 shares of Common Stock (the &#8220;Initial Securities&#8221;) to be<br \/>\npurchased by the Underwriters and all or any part of the 750,000 shares of<br \/>\nCommon Stock subject to the option described in Section 2(b) hereof (the &#8220;Option<br \/>\nSecurities&#8221;) are hereinafter called, collectively, the &#8220;Securities&#8221;.<\/p>\n<p>         The Company and the Selling Shareholders understand that the<br \/>\nUnderwriters propose to make a public offering of the Securities as soon as the<br \/>\nRepresentatives deem advisable after this Agreement has been executed and<br \/>\ndelivered.<\/p>\n<p>         The Company has filed with the Securities and Exchange Commission (the<br \/>\n&#8220;Commission&#8221;) a registration statement on Form S-1 (No. 333-39516) covering the<br \/>\nregistration of the Securities under the Securities Act of 1933, as amended (the<br \/>\n&#8220;1933 Act&#8221;), including the related preliminary prospectus or prospectuses.<br \/>\nPromptly after execution and delivery of this Agreement, the Company will either<br \/>\n(i) prepare and file a prospectus in accordance with the provisions of Rule 430A<br \/>\n(&#8220;Rule 430A&#8221;) of the rules and regulations of the Commission under the 1933 Act<br \/>\n(the &#8220;1933 Act Regulations&#8221;) and paragraph (b) of Rule 424 (&#8220;Rule 424(b)&#8221;) of<br \/>\nthe 1933 Act Regulations or (ii) if the Company has elected to rely upon Rule<br \/>\n434 (&#8220;Rule 434&#8221;) of the 1933 Act Regulations, prepare and file a term sheet (a<br \/>\n&#8220;Term Sheet&#8221;) in accordance with the provisions of Rule 434 and Rule 424(b). The<br \/>\ninformation included in such prospectus or in such Term Sheet, as the case may<br \/>\nbe, that was omitted from such registration statement at the time it became<br \/>\neffective but that is deemed to be part of such registration statement at the<br \/>\ntime it became effective (a) pursuant to paragraph (b) of Rule 430A is referred<br \/>\nto as &#8220;Rule 430A Information&#8221; or (b) pursuant to paragraph (d) of Rule 434 is<br \/>\nreferred to as &#8220;Rule 434 Information.&#8221; Each prospectus used before such<br \/>\nregistration statement became effective, and any prospectus that omitted, as<br \/>\napplicable, the Rule 430A Information or the Rule 434 Information, that was used<br \/>\nafter such effectiveness and prior to the execution and delivery of this<br \/>\nAgreement, is herein called a &#8220;preliminary prospectus.&#8221; Such registration<br \/>\nstatement, including the exhibits thereto and schedules thereto at the time it<br \/>\nbecame effective and including the Rule 430A Information and the Rule 434<br \/>\nInformation, as applicable, is herein called the &#8220;Registration Statement.&#8221; Any<br \/>\nregistration statement filed pursuant to Rule 462(b) of the 1933 Act Regulations<br \/>\nis herein referred to as the &#8220;Rule 462(b) Registration Statement,&#8221; and after<br \/>\nsuch filing the term &#8220;Registration Statement&#8221; shall include the Rule 462(b)<br \/>\nRegistration Statement. The final prospectus in the form first furnished to the<br \/>\nUnderwriters for use in connection with the offering of the Securities is herein<br \/>\ncalled the &#8220;Prospectus&#8221;. If Rule 434 is relied on, the term &#8220;Prospectus&#8221; shall<br \/>\nrefer to the preliminary prospectus dated July 7, 2000 together with the Term<br \/>\nSheet and all references in this Agreement to the date of the Prospectus shall<br \/>\nmean the date of the applicable Term Sheet. For purposes of this Agreement, all<br \/>\nreferences to the<\/p>\n<p>                                        2<br \/>\n   8<br \/>\nRegistration Statement, any preliminary prospectus, the Prospectus or any Term<br \/>\nSheet or any amendment or supplement to any of the foregoing shall be deemed to<br \/>\ninclude the copy filed with the Commission pursuant to its Electronic Data<br \/>\nGathering, Analysis and Retrieval system (&#8220;EDGAR&#8221;).<\/p>\n<p>         SECTION 1.        Representations and Warranties.<\/p>\n<p>         (a) Representations and Warranties by the Company. The Company<br \/>\nrepresents and warrants to each Underwriter as of the date hereof, as of the<br \/>\nClosing Time referred to in Section 2(c) hereof, and as of each Date of Delivery<br \/>\n(if any) referred to in Section 2(b), hereof and agrees with each Underwriter,<br \/>\nas follows:<\/p>\n<p>                  (i) Compliance with Registration Requirements. Each of the<br \/>\n         Registration Statement and any Rule 462(b) Registration Statement has<br \/>\n         become effective under the 1933 Act and no stop order suspending the<br \/>\n         effectiveness of the Registration Statement or any Rule 462(b)<br \/>\n         Registration Statement has been issued under the 1933 Act and no<br \/>\n         proceedings for that purpose have been instituted or are pending or, to<br \/>\n         the knowledge of the Company, are contemplated by the Commission, and<br \/>\n         any request on the part of the Commission for additional information<br \/>\n         has been complied with.<\/p>\n<p>                  At the respective times the Registration Statement, any Rule<br \/>\n         462(b) Registration Statement and any post-effective amendments<br \/>\n         thereto became effective and at the Closing Time (and, if any Option<br \/>\n         Securities are purchased, at the Date of Delivery), the Registration<br \/>\n         Statement, the Rule 462(b) Registration Statement and any amendments<br \/>\n         and supplements thereto complied and will comply in all material<br \/>\n         respects with the requirements of the 1933 Act and the 1933 Act<br \/>\n         Regulations and did not and will not contain an untrue statement of a<br \/>\n         material fact or omit to state a material fact required to be stated<br \/>\n         therein or necessary to make the statements therein not misleading.<br \/>\n         Neither the Prospectus nor any amendment or supplement thereto<br \/>\n         (including any prospectus wrapper), at the time the Prospectus or any<br \/>\n         amendment or supplement thereto was issued and at the Closing Time<br \/>\n         (and, if any Option Securities are purchased, at the Date of Delivery),<br \/>\n         included or will include an untrue statement of a material fact or<br \/>\n         omitted or will omit to state a material fact necessary in order to<br \/>\n         make the statements therein, in the light of the circumstances under<br \/>\n         which they were made, not misleading. If Rule 434 is used, the Company<br \/>\n         will comply with the requirements of Rule 434 and the Prospectus shall<br \/>\n         not be &#8220;materially different&#8221;, as such term is used in Rule 434, from<br \/>\n         the prospectus included in the Registration Statement at the time it<br \/>\n         became effective. The representations and warranties in this subsection<br \/>\n         shall not apply to statements in or omissions from the Registration<br \/>\n         Statement or the Prospectus made in reliance upon and in conformity<br \/>\n         with information<\/p>\n<p>                                        3<br \/>\n   9<br \/>\n         furnished to the Company in writing by any Underwriter through the<br \/>\n         Representatives expressly for use in the Registration Statement or the<br \/>\n         Prospectus.<\/p>\n<p>                  Each preliminary prospectus and the prospectus filed as part<br \/>\n         of the Registra tion Statement as originally filed or as part of any<br \/>\n         amendment thereto, or filed pursuant to Rule 424 under the 1933 Act,<br \/>\n         complied when so filed in all material respects with the 1933 Act<br \/>\n         Regulations and each preliminary prospectus and the Prospectus<br \/>\n         delivered to the Underwriters for use in connection with this offering<br \/>\n         was identical to the electronically transmitted copies thereof filed<br \/>\n         with the Commission pursuant to EDGAR, except to the extent permitted<br \/>\n         by Regulation S-T.<\/p>\n<p>                  (ii) Independent Accountants. The accountants who certified<br \/>\n         the financial statements and supporting schedules included in the<br \/>\n         Registration Statement are independent public accountants as required<br \/>\n         by the 1933 Act and the 1933 Act Regulations.<\/p>\n<p>                  (iii) Financial Statements. The financial statements included<br \/>\n         in the Registra tion Statement and the Prospectus, together with the<br \/>\n         related schedules and notes, present fairly the financial position and<br \/>\n         stockholders&#8217; equity of the Company at the dates indicated and the<br \/>\n         results of operations and cash flows of the Company for the periods<br \/>\n         specified; said financial statements have been prepared in conformity<br \/>\n         with generally accepted accounting principles (&#8220;GAAP&#8221;) applied on a<br \/>\n         consistent basis throughout the periods involved. The selected<br \/>\n         financial and other data and the summary financial and operating data<br \/>\n         included in the Prospectus present fairly the information shown therein<br \/>\n         and, in the cases of the selected financial data and the summary<br \/>\n         financial data, have been compiled on a basis consistent with that of<br \/>\n         the audited financial statements included in the Registration<br \/>\n         Statement.<\/p>\n<p>                  (iv) No Material Adverse Change in Business. Since the<br \/>\n         respective dates as of which information is given in the Registration<br \/>\n         Statement and the Prospectus, except as otherwise stated therein, (A)<br \/>\n         there has been no material adverse change in the condition, financial<br \/>\n         or otherwise, or in the earnings, business affairs or business<br \/>\n         prospects of the Company, whether or not arising in the ordinary course<br \/>\n         of business (a &#8220;Material Adverse Effect&#8221;), (B) there have been no<br \/>\n         transactions entered into by the Company other than those in the<br \/>\n         ordinary course of business, which are material with respect to the<br \/>\n         Company, and (C) there has been no dividend or distribution of any kind<br \/>\n         declared, paid or made by the Company on any class of its capital<br \/>\n         stock.<\/p>\n<p>                  (v) Good Standing of the Company. The Company has been duly<br \/>\n         organized and is validly existing as a corporation in good standing<br \/>\n         under the laws of the State of Delaware and has corporate power and<br \/>\n         authority to own, lease and operate its<\/p>\n<p>                                        4<br \/>\n   10<br \/>\n         properties and to conduct its business as described in the Prospectus<br \/>\n         and to enter into and perform its obligations under this Agreement; and<br \/>\n         the Company is duly qualified as a foreign corporation to transact<br \/>\n         business and is in good standing in each other jurisdiction in which<br \/>\n         such qualification is required, whether by reason of the ownership or<br \/>\n         leasing of property or the conduct of business, except where the<br \/>\n         failure so to qualify or to be in good standing could not reasonably be<br \/>\n         expected to result in a Material Adverse Effect.<\/p>\n<p>                  (vi) No Subsidiaries. The Company has no subsidiaries.<\/p>\n<p>                  (vii) Capitalization. The authorized, issued and outstanding<br \/>\n         capital stock of the Company (a) as of March 31, 2000, was as set forth<br \/>\n         in the Prospectus in the column entitled &#8220;Actual&#8221; under the caption<br \/>\n         &#8220;Capitalization&#8221;, and (b) after giving effect to the transactions<br \/>\n         contemplated by this Agreement and the Registration Statement, will be<br \/>\n         as set forth in the Prospectus in the column entitled &#8220;As Adjusted&#8221;<br \/>\n         under the caption &#8220;Capitalization&#8221; (except for subsequent issuances, if<br \/>\n         any, pursuant to this Agreement, pursuant to reservations, agreements<br \/>\n         or employee benefit plans referred to in the Prospectus or pursuant to<br \/>\n         the exercise of convertible securities, options or warrants referred to<br \/>\n         in the Prospectus). The shares of issued and outstanding capital stock<br \/>\n         of the Company, including, without limitation, the Securities to be<br \/>\n         sold by the Selling Shareholders, have been duly authorized and validly<br \/>\n         issued and are fully paid and non-assessable; none of the outstanding<br \/>\n         shares of capital stock of the Company was issued in violation of the<br \/>\n         preemptive or other similar rights of any securityholder of the<br \/>\n         Company. The shares of issued and outstanding capital stock of the<br \/>\n         Company have been issued in compliance, in all material respects, with<br \/>\n         all federal and state securities laws. Except as disclosed in the<br \/>\n         Prospectus, there are no outstanding options or warrants to purchase,<br \/>\n         or any preemptive rights or other rights to subscribe for or to<br \/>\n         purchase, any securities or obligations convertible into, or any<br \/>\n         contracts or commitments to issue or sell, shares of the Company&#8217;s<br \/>\n         capital stock or any such options, warrants, rights, convertible<br \/>\n         securities or obligations. The description of the Company&#8217;s stock<br \/>\n         option and purchase plans and the options or other rights granted and<br \/>\n         exercised thereunder set forth in the Prospectus accurately and fairly<br \/>\n         describe, in all material respects, the information required to be<br \/>\n         shown with respect to such plans, arrangements, options and rights.<\/p>\n<p>                  (viii) Authorization of Agreement. This Agreement has been<br \/>\n         duly authorized, executed and delivered by the Company.<\/p>\n<p>                  (ix) Authorization and Description of Securities. The<br \/>\n         Securities to be purchased by the Underwriters from the Company have<br \/>\n         been duly authorized for issuance and sale to the Underwriters pursuant<br \/>\n         to this Agreement and, when issued<\/p>\n<p>                                        5<br \/>\n   11<br \/>\n         and delivered by the Company pursuant to this Agreement, against<br \/>\n         payment of the consideration set forth herein will be validly issued,<br \/>\n         fully paid and non-assessable; the Common Stock conforms to all<br \/>\n         statements relating thereto contained in the Prospectus and such<br \/>\n         description conforms to the rights set forth in the instruments<br \/>\n         defining the same; no holder of the Securities will be subject to<br \/>\n         personal liability by reason of being such a holder; and the issuance<br \/>\n         of the Securities is not subject to the preemptive or other similar<br \/>\n         rights of any securityholder of the Company.<\/p>\n<p>                  (x) Absence of Defaults and Conflicts. The Company is not in<br \/>\n         violation of its charter or by-laws or in default in the performance or<br \/>\n         observance of any obligation, agreement, covenant or condition<br \/>\n         contained in any contract, indenture, mortgage, deed of trust, loan or<br \/>\n         credit agreement, note, lease or other agreement or instrument to which<br \/>\n         the Company is a party or by which it may be bound, or to which any of<br \/>\n         the property or assets of the Company is subject (collectively,<br \/>\n         &#8220;Agreements and Instruments&#8221;) except for such defaults under Agreements<br \/>\n         and Instruments that could not reasonably be expected to result in a<br \/>\n         Material Adverse Effect; and the execution, delivery and performance of<br \/>\n         this Agreement and the consummation of the transactions contemplated in<br \/>\n         this Agreement and in the Registration Statement (including the<br \/>\n         issuance and sale of the Securities and the use of the proceeds from<br \/>\n         the sale of the Securities as described in the Prospectus under the<br \/>\n         caption &#8220;Use of Proceeds&#8221;) and compliance by the Company with its<br \/>\n         obligations under this Agreement have been duly authorized by all<br \/>\n         necessary corporate action and do not and will not, whether with or<br \/>\n         without the giving of notice or passage of time or both, conflict with<br \/>\n         or constitute a breach of, or default or Repayment Event (as defined<br \/>\n         below) under, or result in the creation or imposition of any lien,<br \/>\n         charge or encumbrance upon any property or assets of the Company<br \/>\n         pursuant to, the Agreements and Instruments (except for such conflicts,<br \/>\n         breaches or defaults or liens, charges or encumbrances that could not<br \/>\n         reasonably be expected to result in a Material Adverse Effect), nor<br \/>\n         will such action result in any violation of (a) the provisions of the<br \/>\n         charter or by-laws of the Company or (b) any applicable law, statute,<br \/>\n         rule, regulation, judgment, standard, guide, order, writ or decree of<br \/>\n         any government, government instrumentality or court, domestic or<br \/>\n         foreign, having jurisdiction over the Company or any of its assets,<br \/>\n         properties or operations, including, without limitation, the Elementary<br \/>\n         and Secondary Education Act of 1965, as amended, and all rules and<br \/>\n         regulations promulgated thereunder (collectively, the &#8220;ESEA&#8221;), the<br \/>\n         Individuals with Disabilities in Education Act and all rules and<br \/>\n         regulations promulgated thereunder (collectively, the &#8220;IDEA&#8221;) and any<br \/>\n         other federal, state or local law, statute, rule, regulation, standard,<br \/>\n         guide or order pertaining to the authorization to operate public<br \/>\n         schools or the eligibility to receive funding under federal, state or<br \/>\n         local programs related to the operation of public schools, except, in<br \/>\n         the case of clause (b) above, for such violations which could not<br \/>\n         reasonably be expected to result in a Material Adverse Effect. As used<br \/>\n         herein, a &#8220;Repayment<\/p>\n<p>                                        6<br \/>\n   12<br \/>\n         Event&#8221; means any event or condition which gives the holder of any note,<br \/>\n         debenture or other evidence of indebtedness (or any person acting on<br \/>\n         such holder&#8217;s behalf) the right to require the repurchase, redemption<br \/>\n         or repayment of all or a portion of such indebtedness by the Company.<\/p>\n<p>                  (xi) Absence of Labor Dispute. No labor dispute with the<br \/>\n         employees of the Company (including, without limitation, all<br \/>\n         principals, teachers and other personnel employed by or working for or<br \/>\n         in any school operated by the Company) exists or, to the knowledge of<br \/>\n         the Company, is imminent, and the Company is not aware of any existing<br \/>\n         or imminent labor disturbance by the employees of any of its principal<br \/>\n         suppliers, manufacturers, customers or contractors, which, in any of<br \/>\n         the foregoing cases, may reasonably be expected to result in a Material<br \/>\n         Adverse Effect.<\/p>\n<p>                  (xii) Absence of Proceedings. There is no action, suit,<br \/>\n         proceeding, inquiry or investigation before or brought by any court or<br \/>\n         governmental agency or body, domestic or foreign (including, without<br \/>\n         limitation, any proceeding before the United States Department of<br \/>\n         Education (the &#8220;USDE&#8221;), the United States Department of Justice (the<br \/>\n         &#8220;DOJ&#8221;), the Equal Employment Opportunity Commission (the &#8220;EEOC&#8221;), state<br \/>\n         and local educational agencies (including school boards and public<br \/>\n         school districts) or charter school boards), now pending, or, to the<br \/>\n         knowledge of the Company, threatened, against or affecting the Company<br \/>\n         or any school operated by the Company, which is required to be<br \/>\n         disclosed in the Registration Statement (other than as disclosed<br \/>\n         therein), or which could reasonably be expected to result in a Material<br \/>\n         Adverse Effect, or which could materially and adversely affect the<br \/>\n         consummation of the transactions contemplated in this Agreement or the<br \/>\n         performance by the Company of its obligations hereunder or thereunder;<br \/>\n         the aggregate of all pending legal or governmental proceedings to which<br \/>\n         the Company or any school operated by the Company is a party or of<br \/>\n         which any of their respective property or assets is the subject which<br \/>\n         are not described in the Registration Statement, including ordinary<br \/>\n         routine litigation incidental to the business, could not reasonably be<br \/>\n         expected to result in a Material Adverse Effect.<\/p>\n<p>                  (xiii) Accuracy of Exhibits. There are no contracts or<br \/>\n         documents which are required to be described in the Registration<br \/>\n         Statement or the Prospectus or to be filed as exhibits thereto which<br \/>\n         have not been so described and filed as required.<\/p>\n<p>                  (xiv) Possession of Intellectual Property. The Company and<br \/>\n         each of the schools operated by the Company own or possess, or can<br \/>\n         acquire on reasonable terms, adequate patents, patent rights, licenses,<br \/>\n         inventions, copyrights, know-how (including trade secrets and other<br \/>\n         unpatented and\/or unpatentable proprietary or confidential information,<br \/>\n         systems or procedures), trademarks, service marks, trade<\/p>\n<p>                                        7<br \/>\n   13<br \/>\n         names or other intellectual property (including, without limitation,<br \/>\n         the right to use Success for All, a K-5 reading program developed by<br \/>\n         Johns Hopkins University and the mathematics programs developed by the<br \/>\n         University of Chicago School Mathematics Project) (collectively,<br \/>\n         &#8220;Intellectual Property&#8221;) necessary to carry on the business now<br \/>\n         operated by them, and neither the Company nor, to the knowledge of the<br \/>\n         Company, any of the schools operated by it has received any notice or<br \/>\n         is otherwise aware of any infringement of or conflict with asserted<br \/>\n         rights of others with respect to any Intellectual Property or of any<br \/>\n         facts or circumstances which could render any Intellectual Property<br \/>\n         invalid or inadequate to protect the interest of the Company therein,<br \/>\n         and which infringement or conflict (if the subject of any unfavorable<br \/>\n         decision, ruling or finding) or invalidity or inadequacy, singly or in<br \/>\n         the aggregate, could reasonably be expected to result in a Material<br \/>\n         Adverse Effect.<\/p>\n<p>                  (xv) Absence of Further Requirements. No filing with, or<br \/>\n         authorization, approval, consent, license, order, registration,<br \/>\n         qualification or decree of, any court or governmental authority or<br \/>\n         agency is necessary or required for the performance by the Company of<br \/>\n         its obligations hereunder, in connection with the offering, issuance or<br \/>\n         sale of the Securities under this Agreement or the consummation of the<br \/>\n         transactions contemplated by this Agreement, except such as have been<br \/>\n         already obtained or as may be required under the 1933 Act or the 1933<br \/>\n         Act Regulations and foreign or state securities or blue sky laws.<br \/>\n         Neither the Company nor any of the schools operated by the Company is<br \/>\n         subject to any requirements of, or regulation under, the Higher<br \/>\n         Education Act of 1965, as amended.<\/p>\n<p>                  (xvi) Possession of Licenses and Permits. The Company and each<br \/>\n         of the schools operated by it possess such permits, licenses,<br \/>\n         approvals, consents and other authorizations, including, without<br \/>\n         limitation, authorizations required (i) to participate in federal,<br \/>\n         state and local funding programs under the ESEA and the IDEA to the<br \/>\n         extent the Company or such school currently receives material funding<br \/>\n         thereunder, (ii) to operate the charter schools currently operated by<br \/>\n         it, and (iii) to receive funding under federal, state and local<br \/>\n         education laws, statutes, rules, regulations, standards, guides or<br \/>\n         orders to the extent the Company or such school currently receives<br \/>\n         material funding thereunder (collectively, &#8220;Governmental Licenses&#8221;),<br \/>\n         issued by the appropriate federal, state, local or foreign regulatory<br \/>\n         agencies or bodies necessary to conduct the business now operated by<br \/>\n         them, except where the failure to possess such Governmental Licenses<br \/>\n         could not reasonably be expected to have a Material Adverse Effect; the<br \/>\n         Company and, to the knowledge of the Company, each of the schools<br \/>\n         operated by the Company, is in compliance with the terms and conditions<br \/>\n         of all such Governmental Licenses, except where the failure so to<br \/>\n         comply could not, singly or in the aggregate, reasonably be expected to<br \/>\n         have a Material Adverse Effect; all of the Governmental Licenses are<br \/>\n         valid and in full force and effect, except when the<\/p>\n<p>                                        8<br \/>\n   14<br \/>\n         invalidity of such Governmental Licenses or the failure of such<br \/>\n         Governmental Licenses to be in full force and effect could not<br \/>\n         reasonably be expected to have a Material Adverse Effect; and neither<br \/>\n         the Company nor, to the knowledge of the Company, any of the schools<br \/>\n         operated by it has received any notice of proceedings relating to the<br \/>\n         revocation or modification of any such Governmental Licenses which,<br \/>\n         singly or in the aggregate, if the subject of an unfavorable decision,<br \/>\n         ruling or finding, could reasonably be expected to result in a Material<br \/>\n         Adverse Effect.<\/p>\n<p>                  (xvii) Compliance with Statutes, Rules and Regulations, etc.<br \/>\n         The Company and each of the schools operated by it are in compliance<br \/>\n         with all applicable laws, statutes, rules, regulations, standards,<br \/>\n         guides or orders (including, without limitation, ESEA, IDEA, Family<br \/>\n         Education Rights and Privacy Act of 1974, as amended, Gun-Free Schools<br \/>\n         Act of 1994, Section 504 of the Rehabilitation Act of 1973, Americans<br \/>\n         with Disabilities Act of 1990, Title VI and Title VII of the Civil<br \/>\n         Rights Act of 1964, Title IX of the Education Amendments of 1972, Age<br \/>\n         Discrimination Act of 1975, Age Discrimination in Employment Act of<br \/>\n         1967, Equal Pay Act of 1963 and the Drug-Free Workplace Act of 1988)<br \/>\n         administered, issued or implemented by any federal, state or local<br \/>\n         government or any agency or subdivision of any of the foregoing,<br \/>\n         including, without limitation, the USDE, the DOJ, the EEOC, state and<br \/>\n         local education agencies (including school boards and public school<br \/>\n         districts) or charter school boards, to the extent applicable, except<br \/>\n         where failure to be so in compliance could not reasonably be expected<br \/>\n         to have a Material Adverse Effect. The Company has not been advised,<br \/>\n         and has no reason to believe, that either it or any of the schools<br \/>\n         operated by the Company is not conducting business in compliance with<br \/>\n         all applicable laws, statutes, rules and regulations of the<br \/>\n         jurisdictions in which it is conducting business, including, without<br \/>\n         limitation, all applicable federal, state and local laws, rules and<br \/>\n         regulations; except where failure to be so in compliance could not<br \/>\n         reasonably be expected to have a Material Adverse Effect.<\/p>\n<p>                  (xviii) Title to Property. The Company has good and marketable<br \/>\n         title to all real property owned by the Company and good title to all<br \/>\n         other properties owned by it, in each case, free and clear of all<br \/>\n         mortgages, pledges, liens, security interests, claims, restrictions or<br \/>\n         encumbrances of any kind except such as (a) are described in the<br \/>\n         Prospectus or (b) do not, singly or in the aggregate, materially affect<br \/>\n         the value of such property and do not interfere with the use made and<br \/>\n         proposed to be made of such property by the Company; and all of the<br \/>\n         leases and subleases material to the business of the Company and the<br \/>\n         schools operated by it, and under which the Company or any of the<br \/>\n         schools operated by it holds properties described in the Prospectus,<br \/>\n         are in full force and effect, and neither the Company nor any school<br \/>\n         operated by it has any notice of any claim of any sort that has been<br \/>\n         asserted by anyone adverse to the rights of the Company or any of the<br \/>\n         schools operated by it under any<\/p>\n<p>                                        9<br \/>\n   15<br \/>\n         of the leases or subleases mentioned above, or affecting or questioning<br \/>\n         the rights of the Company or any of the schools operated by it to the<br \/>\n         continued possession of the leased or subleased premises under any such<br \/>\n         lease or sublease, which claim, if the subject of an unfavorable<br \/>\n         decision, ruling or finding, could reasonably be expected to result in<br \/>\n         a Material Adverse Effect.<\/p>\n<p>                  (xix) Investment Company Act. The Company is not, and upon the<br \/>\n         issuance and sale of the Securities as herein contemplated and the<br \/>\n         application of the net proceeds therefrom as described in the<br \/>\n         Prospectus will not be, an &#8220;investment company&#8221; as such terms are<br \/>\n         defined in the Investment Company Act of 1940, as amended (the &#8220;1940<br \/>\n         Act&#8221;).<\/p>\n<p>                  (xx) Environmental Laws. Except as described in the<br \/>\n         Registration Statement and except as could not, singly or in the<br \/>\n         aggregate, be reasonably expected to result in a Material Adverse<br \/>\n         Effect, (A) neither the Company nor, to the knowledge of the Company,<br \/>\n         any of the schools operated by it is in violation of any federal,<br \/>\n         state, local or foreign law, statute, rule, regulation, standard,<br \/>\n         guide, ordinance, code, policy or rule of common law or any judicial or<br \/>\n         administrative interpretation thereof, including any judicial or<br \/>\n         administrative order, consent, decree or judgment, relating to<br \/>\n         pollution or protection of human health or safety, the environment<br \/>\n         (including, without limitation, ambient air, surface water,<br \/>\n         groundwater, land surface or subsurface strata), natural resources or<br \/>\n         wildlife, including, without limitation, laws and regulations relating<br \/>\n         to the release or threatened release of chemicals, pollutants,<br \/>\n         contaminants, wastes, toxic substances, hazardous substances<br \/>\n         (including, without limitation, asbestos, polychlorinated biphenyls,<br \/>\n         urea-formaldehyde insulation, petroleum or petroleum products)<br \/>\n         (collectively, &#8220;Hazardous Materials&#8221;) or to the manufacture,<br \/>\n         processing, distribution, use, treatment, storage, disposal, transport<br \/>\n         or handling, release or threatened release of Hazardous Materials<br \/>\n         (collectively, &#8220;Environmental Laws&#8221;), (B) the Company and the schools<br \/>\n         operated by it have all permits, authorizations and approvals required<br \/>\n         under any applicable Environmental Laws and are each in compliance with<br \/>\n         their requirements, (C) there are no pending or threatened<br \/>\n         administrative, regulatory or judicial actions, suits, demands, demand<br \/>\n         letters, claims, liens, notices of noncompliance or violation,<br \/>\n         investigation or proceedings relating to any Environmental Law against<br \/>\n         the Company or any of the schools operated by it, and (D) there are no<br \/>\n         events or circumstances that might reasonably be expected to form the<br \/>\n         basis of an order for clean-up or remediation, or an action, suit or<br \/>\n         proceeding by any private party or governmental body or agency, against<br \/>\n         or affecting the Company or the schools operated by it relating to<br \/>\n         Hazardous Materials or any Environmental Laws.<\/p>\n<p>                                       10<br \/>\n   16<br \/>\n                  (xxi) Registration Rights. Except as disclosed in the<br \/>\n         Prospectus under the caption &#8220;Description of Capital Stock-Registration<br \/>\n         Rights&#8221;, there are no persons with registration rights or other similar<br \/>\n         rights to have any securities registered pursuant to the Registration<br \/>\n         Statement or otherwise registered by the Company under the 1933 Act.<\/p>\n<p>                  (xxii) Apex Online Learning Inc. The Company owns 2,000,000<br \/>\n         shares of Series B preferred stock, par value $0.001 per share, of Apex<br \/>\n         Online Learning Inc., a Washington corporation (&#8220;APEX&#8221;), which<br \/>\n         currently represents approximately 19.7% of all of the issued and<br \/>\n         outstanding capital stock of APEX, free and clear of any security<br \/>\n         interest, mortgage, pledge, lien, encumbrance, claim or equity. The<br \/>\n         Company does not own the equity securities or similar interests of any<br \/>\n         other entity.<\/p>\n<p>                  (xxiii) Management Agreements. The Company has provided to<br \/>\n         Debevoise &amp; Plimpton, counsel for the Underwriters, true, correct and<br \/>\n         complete copies of each of the management agreements and school<br \/>\n         charters to which the Company or any of the schools operated by the<br \/>\n         Company is a party or pursuant to which any such school is operated, as<br \/>\n         amended (collectively, the &#8220;Management Agreements&#8221;), none of which have<br \/>\n         been subsequently amended, supplemented or modified, and each of the<br \/>\n         Management Agreements is in full force and effect on the date hereof,<br \/>\n         and, neither the Company, nor, to the knowledge of Company, any other<br \/>\n         party is in default in the performance or observation of any material<br \/>\n         obligation, agreement, covenant or condition contained therein.<br \/>\n         Schedule E hereto is a true, correct and complete list of the<br \/>\n         Management Agreements.<\/p>\n<p>                  (xxiv) Insurance. The Company and each of the schools operated<br \/>\n         by it and, to the knowledge of the Company, the school districts and<br \/>\n         charter school boards responsible for supervising the schools operated<br \/>\n         by the Company, are insured by insurers of recognized financial<br \/>\n         responsibility against such losses and risks and in such amounts as are<br \/>\n         prudent and customary in the education industry; neither the Company,<br \/>\n         nor any of the schools operated by it nor, to the knowledge of the<br \/>\n         Company, any school district or charter school board responsible for<br \/>\n         supervising any school operated by the Company, has been refused any<br \/>\n         insurance coverage sought or applied for; and the Company does not have<br \/>\n         any reason to believe that it or any of the schools operated by it or<br \/>\n         any school district or charter school board responsible for supervising<br \/>\n         any school operated by the Company, will not be able to renew its<br \/>\n         existing insurance coverage as and when such coverage expires or to<br \/>\n         obtain similar coverage from similar insurers as may be necessary to<br \/>\n         continue its operations except where the failure to renew or maintain<br \/>\n         such coverage could not reasonably be expected to result in a Material<br \/>\n         Adverse Effect. The officers and directors of the Company are insured<br \/>\n         by insurers of recognized financial responsibility against such losses<br \/>\n         and risks and in<\/p>\n<p>                                       11<br \/>\n   17<br \/>\n         such amounts as the Company believes are prudent and customary for<br \/>\n         officers&#8217; and directors&#8217; liability insurance of a public company and as<br \/>\n         the Company believes could cover claims which could reasonably be<br \/>\n         expected to be made in connection with the issuance of the Securities;<br \/>\n         and the Company has no reason to believe that it will not be able to<br \/>\n         renew its existing directors&#8217; and officers&#8217; liability insurance<br \/>\n         coverage as and when such coverage expires or to obtain similar<br \/>\n         coverage from similar insurers as may be necessary to cover its<br \/>\n         officers and directors.<\/p>\n<p>                  (xxv) Tax Returns and Payment of Taxes. The Company has timely<br \/>\n         filed all federal, state, local and foreign tax returns that are<br \/>\n         required to be filed or has duly requested extensions thereof and all<br \/>\n         such tax returns are true, correct and complete, except to the extent<br \/>\n         that any failure to file or request an extension, or any incorrect ness<br \/>\n         could not reasonably be expected to result in a Material Adverse<br \/>\n         Effect. The Company has timely paid all taxes shown as due on such<br \/>\n         filed tax returns (including any related assessments, fines or<br \/>\n         penalties), except to the extent that any such taxes are being<br \/>\n         contested in good faith and by appropriate proceedings, or to the<br \/>\n         extent that any failure to pay could not reasonably be expected to<br \/>\n         result in a Material Adverse Effect; and adequate charges, accruals and<br \/>\n         reserves have been provided for in the financial statements referred to<br \/>\n         in Section 1(a)(iii) above in accordance with GAAP in respect of all<br \/>\n         Federal, state, local and foreign taxes for all periods as to which the<br \/>\n         tax liability of the Company has not been finally determined or remains<br \/>\n         open to examination by applicable taxing authorities. The Company is<br \/>\n         not a &#8220;United States real property holding corporation&#8221; within the<br \/>\n         meaning of Section 897(c)(2) of the Internal Revenue Code of 1986, as<br \/>\n         amended (the &#8220;Code&#8221;).<\/p>\n<p>                  (xxvi) No Stabilization or Manipulation. Neither the Company<br \/>\n         nor, to the best of its knowledge, any of its directors, officers or<br \/>\n         affiliates has taken or will take, directly or indirectly, any action<br \/>\n         designed to, or that might be reasonably expected to, cause or result<br \/>\n         in stabilization or manipulation of the price of the Securities in<br \/>\n         violation of Regulation M under the Securities Exchange Act of 1934, as<br \/>\n         amended (the &#8220;1934 Act&#8221;).<\/p>\n<p>                  (xxvii) Certain Transactions. Except as disclosed in the<br \/>\n         Prospectus, there are no outstanding loans, advances, or guarantees of<br \/>\n         indebtedness by the Company to or for the benefit of any of the<br \/>\n         executive officers or directors of the Company or any of the members of<br \/>\n         the families of any of them that would be required to be so disclosed<br \/>\n         under the 1933 Act, the 1933 Act Regulations or Form S-1.<\/p>\n<p>                  (xxviii) Statistical and Market Data. The statistical and<br \/>\n         market-related data included in the Prospectus are derived from sources<br \/>\n         which the Company reasonably<\/p>\n<p>                                       12<br \/>\n   18<br \/>\n         and in good faith believes to be accurate, reasonable and reliable and<br \/>\n         agrees with the sources from which it was derived.<\/p>\n<p>                  (xxix) Accounting and other Controls. The Company has<br \/>\n         established a system of internal accounting controls sufficient to<br \/>\n         provide reasonable assurances that (i) transactions were, are and will<br \/>\n         be executed in accordance with management&#8217;s general or specific<br \/>\n         authorization; (ii) transactions were, are and will be recorded as<br \/>\n         necessary to permit preparation of financial statements in conformity<br \/>\n         with generally accepted accounting principles and to maintain<br \/>\n         accountability for assets; (iii) access to assets was, is and will be<br \/>\n         permitted only in accordance with a management&#8217;s general or specific<br \/>\n         authorizations; and (iv) the recorded accountability for assets was, is<br \/>\n         and will be compared with existing assets at reasonable intervals and<br \/>\n         appropriate action was, is and will be taken with respect to any<br \/>\n         differences.<\/p>\n<p>         (b) Representations and Warranties by the Selling Shareholders. Each<br \/>\nSelling Shareholder severally represents and warrants to each Underwriter as of<br \/>\nthe date hereof, as of the Closing Time, and, if the Selling Shareholder is<br \/>\nselling Option Securities on a Date of Delivery, as of each such Date of<br \/>\nDelivery, and agrees with each Underwriter, as follows:<\/p>\n<p>                  (i) Accurate Disclosure. Such Selling Shareholder has reviewed<br \/>\n         and is familiar with the Registration Statement and the Prospectus and,<br \/>\n         to the best knowledge of such Selling Shareholder, neither the<br \/>\n         Prospectus nor any amendments or supplements thereto (including any<br \/>\n         prospectus wrapper) includes any untrue statement of a material fact or<br \/>\n         omits to state a material fact necessary in order to make the<br \/>\n         statements therein, in the light of the circumstances under which they<br \/>\n         were made, not misleading; such Selling Shareholder is not prompted to<br \/>\n         sell the Securities to be sold by such Selling Shareholder under this<br \/>\n         Agreement by any information concerning the Company or any subsidiary<br \/>\n         of the Company which is not set forth in the Prospectus.<\/p>\n<p>                  (ii) Authorization of Agreements. Such Selling Shareholder has<br \/>\n         the full right, power and authority to enter into this Agreement, and a<br \/>\n         Power of Attorney (the &#8220;Power of Attorney&#8221;) and a Custody Agreement<br \/>\n         (the &#8220;Custody Agreement&#8221;) and to sell, transfer and deliver the<br \/>\n         Securities to be sold by such Selling Shareholder under this Agreement.<br \/>\n         The execution and delivery of this Agreement, the Power of Attorney and<br \/>\n         the Custody Agreement, the sale and delivery of the Securities to be<br \/>\n         sold by such Selling Shareholder, the consummation by such Selling<br \/>\n         Shareholder of the transactions contemplated under this Agreement and<br \/>\n         compliance by such Selling Shareholder with its obligations under this<br \/>\n         Agreement have been duly authorized by such Selling Shareholder and do<br \/>\n         not and will not, whether with or without the giving of notice or<br \/>\n         passage of time or both, conflict with or constitute a breach of, or<br \/>\n         default<\/p>\n<p>                                       13<br \/>\n   19<br \/>\n         under, or result in the creation or imposition of any tax, lien, charge<br \/>\n         or encumbrance upon the Securities to be sold by such Selling<br \/>\n         Shareholder or any property or assets of such Selling Shareholder<br \/>\n         pursuant to any contract, indenture, mortgage, deed of trust, loan or<br \/>\n         credit agreement, note, license, lease or other agreement or instrument<br \/>\n         to which such Selling Shareholder is a party or by which such Selling<br \/>\n         Shareholder may be bound, or to which any of the property or assets of<br \/>\n         such Selling Shareholder is subject, nor will such action result in any<br \/>\n         violation of the provisions of the charter or by-laws or other<br \/>\n         organizational instrument of such Selling Shareholder, if applicable,<br \/>\n         or any applicable treaty, law, statute, rule, regulation, judgment,<br \/>\n         order, writ or decree of any government, government instrumentality or<br \/>\n         court, domestic or foreign, having jurisdiction over such Selling<br \/>\n         Shareholder or any of its properties.<\/p>\n<p>                  (iii) Valid and Marketable Title. Such Selling Shareholder (i)<br \/>\n         has at the date hereof (excluding Richmont Capital Partners I, L.P.)<br \/>\n         valid and marketable title to the Securities to be sold by such Selling<br \/>\n         Shareholder under this Agreement or to the options or warrants that<br \/>\n         will be exercised for such Securities prior to the Closing Time, in<br \/>\n         each case free and clear of any security interest, mortgage, pledge,<br \/>\n         lien, charge, claim, equity or encumbrance of any kind (collectively,<br \/>\n         the &#8220;Lien&#8221;), other than pursuant to this Agreement, and (ii) will at<br \/>\n         the Closing Time (including Richmont Capital Partners I, L.P.) and, if<br \/>\n         any Option Securities are purchased, on the Date of Delivery, have<br \/>\n         valid and marketable title to the Securities to be sold by such Selling<br \/>\n         Shareholder under this Agreement, including any Securities received as<br \/>\n         result of exercises of options or warrants, free and clear of any Lien,<br \/>\n         other than pursuant to this Agreement; and upon delivery of such<br \/>\n         Securities and payment of the purchase price therefor as contemplated<br \/>\n         in this Agreement (assuming each such Underwriter has no notice of any<br \/>\n         adverse claim, as defined in Uniform Commercial Code as adopted in the<br \/>\n         State of New York (the &#8220;UCC&#8221;)), each of the Underwriters will receive<br \/>\n         valid and marketable title to the Securities purchased by it from such<br \/>\n         Selling Shareholder, free and clear of any Lien.<\/p>\n<p>                  (iv) Due Execution of Power of Attorney and Custody Agreement.<br \/>\n         Such Selling Shareholder has duly executed and delivered, in the form<br \/>\n         heretofore furnished to the Representatives, the Power of Attorney with<br \/>\n         David A. Graff, Laura K. Eshbaugh and James L. Starr, or any of them,<br \/>\n         as attorneys-in-fact (the &#8220;Attorneys-in-Fact&#8221;) and the Custody<br \/>\n         Agreement with the Company, as custodian (the &#8220;Custodian&#8221;); the<br \/>\n         Custodian is authorized to deliver the Securities to be sold by such<br \/>\n         Selling Shareholder under this Agreement and to accept payment<br \/>\n         therefor; and each Attorney-in-Fact is authorized to execute and<br \/>\n         deliver this Agreement and the certificate referred to in Section 5(f)<br \/>\n         or that may be required pursuant to Sections 5(m) and 5(n) of this<br \/>\n         Agreement on behalf of such Selling Shareholder, to sell, assign and<br \/>\n         transfer to the Underwriters the Securities to be sold by such Selling<br \/>\n         Shareholder<\/p>\n<p>                                       14<br \/>\n   20<br \/>\n         under this Agreement, to determine the purchase price to be paid by the<br \/>\n         Underwriters and to such Selling Shareholder, as provided in Section<br \/>\n         2(a) of this Agreement, to authorize the delivery of the Securities to<br \/>\n         be sold by such Selling Shareholder under this Agreement, to accept<br \/>\n         payment therefor, and otherwise to act on behalf of such Selling<br \/>\n         Shareholder in connection with this Agreement.<\/p>\n<p>                  (v) Absence of Manipulation. Such Selling Shareholder has not<br \/>\n         taken, and will not take, directly or indirectly, any action designed<br \/>\n         to, or that might reasonably be expected to cause or result in<br \/>\n         stabilization or manipulation of the price of the Securities in<br \/>\n         violation of Regulation M under the 1934 Act.<\/p>\n<p>                  (vi) Absence of Further Requirements. No filing with, or<br \/>\n         authorization, approval, consent, license, order, registration,<br \/>\n         qualification or decree of, any court or governmental authority or<br \/>\n         agency is necessary or required for the performance by such Selling<br \/>\n         Shareholder of its obligations under this Agreement or in the Power of<br \/>\n         Attorney or the Custody Agreement, or in connection with the offer,<br \/>\n         sale and delivery by such Selling Shareholder of the Securities under<br \/>\n         this Agreement or the consummation by such Selling Shareholder of the<br \/>\n         transactions contemplated by this Agreement, except such as have been<br \/>\n         already obtained or as may be required under the 1933 Act or the 1933<br \/>\n         Act Regulations and state securities laws.<\/p>\n<p>                  (vii) Restriction on Sale of Securities. During a period of 90<br \/>\n         days from the date of the Prospectus, such Selling Shareholder will<br \/>\n         not, without the prior written consent of Merrill Lynch, (i) offer,<br \/>\n         pledge, sell, contract to sell, sell any option or contract to<br \/>\n         purchase, purchase any option or contract to sell, grant any option,<br \/>\n         right or warrant to purchase or otherwise lend, transfer or dispose of,<br \/>\n         directly or indirectly, any share of Common Stock, class B common stock<br \/>\n         or any securities convertible into, exercisable or exchangeable for or<br \/>\n         repayable with Common Stock or class B common stock, whether now owned<br \/>\n         or hereafter acquired by such Selling Shareholder or with respect to<br \/>\n         which such Selling Shareholder has or hereafter acquires the power of<br \/>\n         disposition, or file, or request or demand that the Company file, any<br \/>\n         registration statement under the 1933 Act with respect to any of the<br \/>\n         foregoing or (ii) enter into any swap or any other agreement or any<br \/>\n         transaction that transfers, in whole or in part, directly or<br \/>\n         indirectly, the economic consequence of ownership of the Common Stock<br \/>\n         or class B common stock, whether any such swap or transaction described<br \/>\n         in clause (i) or (ii) above is to be settled by delivery of Common<br \/>\n         Stock, class B common stock or such other securities, in cash or<br \/>\n         otherwise. The foregoing sentence shall not apply to the Securities to<br \/>\n         be sold under this Agreement.<\/p>\n<p>                  (viii) Certificates Suitable for Transfer. Certificates for<br \/>\n         all of the Securities to be sold by such Selling Shareholder pursuant<br \/>\n         to this Agreement, in suitable form<\/p>\n<p>                                       15<br \/>\n   21<br \/>\n         for transfer by delivery or accompanied by duly executed instruments of<br \/>\n         transfer or assignment in blank with signatures guaranteed, have been<br \/>\n         placed in custody with the Custodian with irrevocable conditional<br \/>\n         instructions to deliver such Securities to the Underwriters pursuant to<br \/>\n         this Agreement.<\/p>\n<p>                  (ix) No Association with NASD. Neither such Selling<br \/>\n         Shareholder, nor any of its affiliates directly, or indirectly through<br \/>\n         one or more intermediaries, controls, or is controlled by, or is under<br \/>\n         common control with, or has any other association with (within the<br \/>\n         meaning of Article I, Section (ee) of the By-laws of the National<br \/>\n         Association of Securities Dealers, Inc. (the &#8220;NASD&#8221;) any member firm of<br \/>\n         the NASD.<\/p>\n<p>         (c) Officer&#8217;s Certificates. Any certificate signed by any officer of<br \/>\nthe Company delivered to Merrill Lynch, the Representatives or to counsel for<br \/>\nthe Underwriters shall be deemed a representation and warranty by the Company to<br \/>\neach Underwriter as to the matters covered thereby; and any certificate signed<br \/>\nby or on behalf of the Selling Shareholders as such and delivered to Merrill<br \/>\nLynch, the Representatives or to counsel for the Underwriters shall be deemed a<br \/>\nrepresentation and warranty by such Selling Shareholder to the Underwriters as<br \/>\nto the matters covered thereby.<\/p>\n<p>         SECTION 2.        Sale and Delivery to Underwriters; Closing.<\/p>\n<p>         (a) Initial Securities. On the basis of the representations and<br \/>\nwarranties herein contained and subject to the terms and conditions herein set<br \/>\nforth, the Company and each Selling Shareholder, severally and not jointly,<br \/>\nagree to sell to each Underwriter, severally and not jointly, and each<br \/>\nUnderwriter, severally and not jointly, agrees to purchase from the Company and<br \/>\neach Selling Shareholder, at the price per share set forth in Schedule C, that<br \/>\nproportion of the number of Initial Securities set forth in Schedule B opposite<br \/>\nthe name of the Company or such Selling Shareholder, as the case may be, which<br \/>\nthe number of Initial Securities set forth in Schedule A opposite the name of<br \/>\nsuch Underwriter, plus any additional number of Initial Securities which such<br \/>\nUnderwriter may become obligated to purchase pursuant to the provisions of<br \/>\nSection 10 hereof, bears to the total number of Initial Securities, subject, in<br \/>\neach case, to such adjustments among the Underwriters as the Representatives in<br \/>\ntheir sole discretion shall make to eliminate any sales or purchases of<br \/>\nfractional securities.<\/p>\n<p>         (b) Option Securities. In addition, on the basis of the representations<br \/>\nand warranties herein contained and subject to the terms and conditions herein<br \/>\nset forth, the Company and the Selling Shareholders, acting severally and not<br \/>\njointly, hereby grant an option to the Underwriters, severally and not jointly,<br \/>\nto purchase up to an additional 750,000 shares of Common Stock, as set forth in<br \/>\nSchedule B, at the price per share set forth in Schedule C, less an amount per<br \/>\nshare equal to any dividends or distributions declared by the<\/p>\n<p>                                       16<br \/>\n   22<br \/>\nCompany and payable on the Initial Securities but not payable on the Option<br \/>\nSecurities. The option hereby granted will expire 30 days after the date hereof<br \/>\nand may be exercised in whole or in part from time to time only for the purpose<br \/>\nof covering over-allotments which may be made in connection with the offering<br \/>\nand distribution of the Initial Securities upon notice by the Representatives to<br \/>\nthe Company and the Selling Shareholders setting forth the number of Option<br \/>\nSecurities as to which the several Underwriters are then exercising the option<br \/>\nand the time and date of payment and delivery for such Option Securities. Any<br \/>\nsuch time and date of delivery for the Option Securities (a &#8220;Date of Delivery&#8221;)<br \/>\nshall be determined by the Representatives, but shall not be later than seven<br \/>\nfull business days after the exercise of said option, nor in any event prior to<br \/>\nthe Closing Time, as hereinafter defined. If the option is exercised as to all<br \/>\nor any portion of the Option Securities, the purchase of Option Securities shall<br \/>\nbe made initially among the Selling Shareholders in proportion to the maximum<br \/>\nnumber of Option Securities to be sold by each Selling Shareholder as set forth<br \/>\nin Schedule B until the Selling Shareholders have sold the maximum number of<br \/>\nOption Securities to be sold by the Selling Shareholders as set forth in<br \/>\nSchedule B and then from the Company, and each of the Underwriters, acting<br \/>\nseverally and not jointly, will purchase that proportion of the total number of<br \/>\nOption Securities then being purchased which the number of Initial Securities<br \/>\nset forth in Schedule A opposite the name of such Underwriter bears to the total<br \/>\nnumber of Initial Securities, subject in each case to such adjustments as the<br \/>\nRepresentatives in their discretion shall make to eliminate any sales or<br \/>\npurchases of fractional shares.<\/p>\n<p>         (c) Payment. Payment of the purchase price for, and delivery of<br \/>\ncertificates for, the Initial Securities shall be made at the offices of<br \/>\nDebevoise &amp; Plimpton, 875 Third Avenue, New York, NY 10022, or at such other<br \/>\nplace as shall be agreed upon by the Representatives and the Company and the<br \/>\nSelling Shareholders, at 9:00 A.M. (New York city time) on the third (fourth, if<br \/>\nthe pricing occurs after 4:30 P.M. (New York city time) on any given day)<br \/>\nbusiness day after the date hereof (unless postponed in accordance with the<br \/>\nprovisions of Section 10), or such other time not later than ten business days<br \/>\nafter such date as shall be agreed upon by the Representatives and the Company<br \/>\nand the Selling Shareholders (such time and date of payment and delivery being<br \/>\nherein called &#8220;Closing Time&#8221;).<\/p>\n<p>         In addition, in the event that any or all of the Option Securities are<br \/>\npurchased by the Underwriters, payment of the purchase price for, and delivery<br \/>\nof certificates for, such Option Securities shall be made at the above-mentioned<br \/>\noffices, or at such other place as shall be agreed upon by the Representatives<br \/>\nand the Company and the Selling Shareholders, on each Date of Delivery as<br \/>\nspecified in the notice from the Representatives to the Company and the Selling<br \/>\nShareholders.<\/p>\n<p>         Payment shall be made to the Company and the Selling Shareholders by<br \/>\nwire transfer of immediately available funds to bank accounts designated by the<br \/>\nCompany and the Custodian pursuant to each Selling Shareholder&#8217;s Power of<br \/>\nAttorney and Custody Agreement,<\/p>\n<p>                                       17<br \/>\n   23<br \/>\nas the case may be, against delivery to the Representatives for the respective<br \/>\naccounts of the Underwriters of certificates for the Securities to be purchased<br \/>\nby them. It is understood that each Underwriter has authorized the<br \/>\nRepresentatives, for its account, to accept delivery of, receipt for, and make<br \/>\npayment of the purchase price for, the Initial Securities and the Option<br \/>\nSecurities, if any, which it has agreed to purchase. Merrill Lynch, individually<br \/>\nand not as representative of the Underwriters, may (but shall not be obligated<br \/>\nto) make payment of the purchase price for the Initial Securities or the Option<br \/>\nSecurities, if any, to be purchased by any Underwriter whose funds have not been<br \/>\nreceived by the Closing Time or the relevant Date of Delivery, as the case may<br \/>\nbe, but such payment shall not relieve such Underwriter from its obligations<br \/>\nhereunder.<\/p>\n<p>         (d) Denominations; Registration. Certificates for the Initial<br \/>\nSecurities and the Option Securities, if any, shall be in such denominations and<br \/>\nregistered in such names as the Representatives may request in writing at least<br \/>\none full business day before the Closing Time or the relevant Date of Delivery,<br \/>\nas the case may be. The certificates for the Initial Securities and the Option<br \/>\nSecurities, if any, will be made available for examination and packaging by the<br \/>\nRepresentatives in The City of New York not later than 10:00 A.M. (Eastern time)<br \/>\non the business day prior to the Closing Time or the relevant Date of Delivery,<br \/>\nas the case may be.<\/p>\n<p>         SECTION 3.  Covenants of the Company.  The Company covenants with each<br \/>\nUnderwriter as follows:<\/p>\n<p>                  (a) Compliance with Securities Regulations and Commission<br \/>\n         Requests. The Company, subject to Section 3(b), will comply with the<br \/>\n         requirements of Rule 430A or Rule 434, as applicable, and will notify<br \/>\n         the Representatives immediately, and confirm the notice in writing, (i)<br \/>\n         when any post-effective amendment to the Registra tion Statement shall<br \/>\n         become effective, or any supplement to the Prospectus or any amended<br \/>\n         Prospectus shall have been filed, (ii) of the receipt of any comments<br \/>\n         from the Commission, (iii) of any request by the Commission for any<br \/>\n         amendment to the Registration Statement or any amendment or supplement<br \/>\n         to the Prospectus or for additional information, and (iv) of the<br \/>\n         issuance by the Commission of any stop order suspending the<br \/>\n         effectiveness of the Registration Statement or of any order preventing<br \/>\n         or suspending the use of any preliminary prospectus, or of the<br \/>\n         suspension of the qualification of the Securities for offering or sale<br \/>\n         in any jurisdiction, or of the initiation or threatening of any<br \/>\n         proceedings for any of such purposes. The Company will promptly effect<br \/>\n         the filings necessary pursuant to Rule 424(b) and will take such steps<br \/>\n         as it deems necessary to ascertain promptly whether the form of<br \/>\n         prospectus transmitted for filing under Rule 424(b) was received for<br \/>\n         filing by the Commission and, in the event that it was not, it will<br \/>\n         promptly file such prospectus. The Company<\/p>\n<p>                                       18<br \/>\n   24<br \/>\n         will make every reasonable effort to prevent the issuance of any stop<br \/>\n         order and, if any stop order is issued, to obtain the lifting thereof<br \/>\n         at the earliest possible moment.<\/p>\n<p>                  (b) Filing of Amendments. The Company will give the<br \/>\n         Representatives notice of its intention to file or prepare any<br \/>\n         amendment to the Registration Statement (including any filing under<br \/>\n         Rule 462(b)), any Term Sheet or any amendment, supplement or revision<br \/>\n         to either the prospectus included in the Registration Statement at the<br \/>\n         time it became effective or to the Prospectus, will furnish the<br \/>\n         Representatives with copies of any such documents a reasonable amount<br \/>\n         of time prior to such proposed filing or use, as the case may be, and<br \/>\n         will not file or use any such document to which the Representatives or<br \/>\n         counsel for the Underwriters shall reasonably object.<\/p>\n<p>                  (c) Delivery of Registration Statements. The Company has<br \/>\n         furnished or will deliver to the Representatives and counsel for the<br \/>\n         Underwriters, without charge, signed copies of the Registration<br \/>\n         Statement as originally filed and of each amendment thereto (including<br \/>\n         exhibits filed therewith or incorporated by reference therein) and<br \/>\n         signed copies of all consents and certificates of experts, and will<br \/>\n         also deliver to the Representatives, without charge, a conformed copy<br \/>\n         of the Registration Statement as originally filed and of each amendment<br \/>\n         thereto (without exhibits) for each of the Underwriters. The copies of<br \/>\n         the Registration Statement and each amendment thereto furnished to the<br \/>\n         Underwriters will be identical to the electronically transmitted copies<br \/>\n         thereof filed with the Commission pursuant to EDGAR, except to the<br \/>\n         extent permitted by Regulation S-T.<\/p>\n<p>                  (d) Delivery of Prospectus. The Company has delivered to each<br \/>\n         Underwriter, without charge, as many copies of each preliminary<br \/>\n         prospectus as such Underwriter reasonably requested, and the Company<br \/>\n         hereby consents to the use of such copies for purposes permitted by the<br \/>\n         1933 Act. The Company will furnish to each Underwriter, without charge,<br \/>\n         during the period when the Prospectus is required to be delivered under<br \/>\n         the 1933 Act or the 1934 Act, such number of copies of the Prospectus<br \/>\n         (as amended or supplemented) as such Underwriter may reasonably<br \/>\n         request. The Prospectus and any amendments or supplements thereto<br \/>\n         furnished to the Underwriters will be identical to the electronically<br \/>\n         transmitted copies thereof filed with the Commission pursuant to EDGAR,<br \/>\n         except to the extent permitted by Regulation S-T.<\/p>\n<p>                  (e) Continued Compliance with Securities Laws. The Company<br \/>\n         will comply with the 1933 Act, the 1933 Act Regulations, the 1934 Act<br \/>\n         and the 1934 Act Regulations so as to permit the completion of the<br \/>\n         distribution of the Securities as contemplated in this Agreement, and<br \/>\n         in the Prospectus. If at any time when a prospectus is required by the<br \/>\n         1933 Act or the 1934 Act to be delivered in connection<\/p>\n<p>                                       19<br \/>\n   25<br \/>\n         with sales of the Securities, any event shall occur or condition shall<br \/>\n         exist as a result of which it is necessary, in the opinion of counsel<br \/>\n         for the Underwriters or for the Company, to amend the Registration<br \/>\n         Statement or amend or supplement the Prospectus in order that the<br \/>\n         Prospectus will not include any untrue statements of a material fact or<br \/>\n         omit to state a material fact necessary in order to make the statements<br \/>\n         therein not misleading in the light of the circumstances existing at<br \/>\n         the time it is delivered to a purchaser, or if it shall be necessary,<br \/>\n         in the opinion of such counsel, at any such time to amend the<br \/>\n         Registration Statement or amend or supplement the Prospectus in order<br \/>\n         to comply with the requirements of the 1933 Act, the 1933 Act<br \/>\n         Regulations, the 1934 Act or the 1934 Act Regulations, the Company will<br \/>\n         promptly prepare and file with the Commission, subject to Section 3(b),<br \/>\n         such amendment or supplement as may be necessary to correct such<br \/>\n         statement or omission or to make the Registration Statement or the<br \/>\n         Prospectus comply with such requirements, and the Company will furnish<br \/>\n         to the Underwriters such number of copies of such amendment or<br \/>\n         supplement as the Underwriters may reasonably request.<\/p>\n<p>                  (f) Blue Sky Qualifications. The Company will use its best<br \/>\n         efforts, in cooperation with the Underwriters, to qualify the<br \/>\n         Securities for offering and sale under the applicable securities laws<br \/>\n         of such states and other jurisdictions (domestic or foreign) as the<br \/>\n         Representatives may designate and to maintain such qualifications in<br \/>\n         effect for a period of not less than one year from the later of the<br \/>\n         effective date of the Registration Statement and any Rule 462(b)<br \/>\n         Registration Statement; provided, however, that the Company shall not<br \/>\n         be obligated to file any general consent to service of process or to<br \/>\n         qualify as a foreign corporation or as a dealer in securities in any<br \/>\n         jurisdiction in which it is not so qualified or to subject itself to<br \/>\n         taxation in respect of doing business in any jurisdiction in which it<br \/>\n         is not otherwise so subject. In each jurisdiction in which the<br \/>\n         Securities have been so qualified, the Company will file such<br \/>\n         statements and reports as may be required by the laws of such<br \/>\n         jurisdiction to continue such qualification in effect for a period of<br \/>\n         not less than one year from the effective date of the Registration<br \/>\n         Statement and any Rule 462(b) Registration Statement.<\/p>\n<p>                  (g) Rule 158. The Company will timely file such reports<br \/>\n         pursuant to the 1934 Act as are necessary in order to make generally<br \/>\n         available to its securityholders as soon as practicable an earnings<br \/>\n         statement for the purposes of, and to provide the benefits contemplated<br \/>\n         by, the last paragraph of Section 11(a) of the 1933 Act.<\/p>\n<p>                  (h) Use of Proceeds. The Company will use the net proceeds<br \/>\n         received by it from the sale of the Securities in the manner specified<br \/>\n         in the Prospectus under &#8220;Use of Proceeds&#8221;.<\/p>\n<p>                                       20<br \/>\n   26<br \/>\n                  (i) Listing. The Company will use its best efforts to effect<br \/>\n         and maintain the quotation of the Securities on the Nasdaq National<br \/>\n         Market and will file with the Nasdaq National Market all documents and<br \/>\n         notices required by the Nasdaq National Market of companies that have<br \/>\n         securities that are traded in the over-the-counter market and<br \/>\n         quotations for which are reported by the Nasdaq National Market.<\/p>\n<p>                  (j) Restriction on Sale of Securities. During a period of 90<br \/>\n         days from the date of the Prospectus, the Company will not, without the<br \/>\n         prior written consent of Merrill Lynch, (i) directly or indirectly,<br \/>\n         offer, pledge, sell, contract to sell, sell any option or contract to<br \/>\n         purchase, purchase any option or contract to sell, grant any option,<br \/>\n         right or warrant to purchase or otherwise transfer or dispose of any<br \/>\n         share of Common Stock or class B common stock or any securities<br \/>\n         convertible into or exercisable or exchangeable for Common Stock or<br \/>\n         class B common stock or file any registration statement under the 1933<br \/>\n         Act with respect to any of the foregoing or (ii) enter into any swap or<br \/>\n         any other agreement or any transaction that transfers, in whole or in<br \/>\n         part, directly or indirectly, the economic consequence of ownership of<br \/>\n         the Common Stock or the class B common stock, whether any such swap or<br \/>\n         the transaction described in clause (i) or (ii) above is to be settled<br \/>\n         by delivery of Common Stock, class B common stock or such other<br \/>\n         securities, in cash or otherwise. The foregoing sentence shall not<br \/>\n         apply to (A) the Securities to be sold hereunder, (B) any shares of<br \/>\n         Common Stock or class B common stock issued by the Company upon the<br \/>\n         exercise of an option or warrant or the conversion of a security<br \/>\n         outstanding on the date hereof and referred to in the Prospectus, or<br \/>\n         (C) any shares of Common Stock or class B common stock issued or<br \/>\n         options to purchase shares of Common Stock or class B common stock<br \/>\n         granted pursuant to existing employee benefit plans of the Company<br \/>\n         referred to in the Prospectus or (D) any shares of Common Stock that<br \/>\n         may be issued by the Company from time to time upon the conversion of<br \/>\n         shares of class B common stock into shares of Common Stock pursuant to<br \/>\n         its sixth amended and restated certificate of incorporation.<\/p>\n<p>                  (k) Reporting Requirements. The Company, during the period<br \/>\n         when the Prospectus are required to be delivered under the 1933 Act or<br \/>\n         the 1934 Act, will file all documents required to be filed with the<br \/>\n         Commission pursuant to the 1934 Act within the time periods required by<br \/>\n         the 1934 Act and the rules and regulations of the Commission<br \/>\n         thereunder.<\/p>\n<p>                                       21<\/p>\n<p>   27<br \/>\n         SECTION 4. Payment of Expenses.<\/p>\n<p>         (a) Expenses. The Company will pay all expenses incident to the<br \/>\nperformance of its obligations under this Agreement, including (i) the<br \/>\npreparation, printing and filing of the Registration Statement (including<br \/>\nfinancial statements and exhibits) as originally filed and of each amendment<br \/>\nthereto, (ii) the preparation, printing and delivery to the Underwriters of this<br \/>\nAgreement, any Agreement among Underwriters and such other documents as may be<br \/>\nrequired in connection with the offering, purchase, sale, issuance or delivery<br \/>\nof the Securities, (iii) the preparation, issuance and delivery of the<br \/>\ncertificates for the Securities to the Underwriters, including any stock or<br \/>\nother transfer taxes and any stamp or other duties payable upon the sale,<br \/>\nissuance or delivery of the Securities to the Underwriters, (iv) the fees and<br \/>\ndisbursements of the Company&#8217;s counsel, accountants and other advisors, (v) the<br \/>\nqualification of the Securities under securities laws in accordance with the<br \/>\nprovisions of Section 3(f) hereof, including filing fees and the reasonable fees<br \/>\nand disbursements of counsel for the Underwriters in connection therewith and in<br \/>\nconnection with the preparation of the Blue Sky Survey and any supplement<br \/>\nthereto, (vi) the printing and delivery to the Underwriters of copies of each<br \/>\npreliminary prospectus, any Term Sheets and of the Prospectus and any amendments<br \/>\nor supplements thereto, (vii) the preparation, printing and delivery to the<br \/>\nUnderwriters of copies of the Blue Sky Survey and any supplement thereto, (viii)<br \/>\nthe fees and expenses of any transfer agent or registrar for the Securities,<br \/>\n(ix) the filing fees incident to, and the reasonable fees and disbursements of<br \/>\ncounsel to the Underwriters in connection with, the review by the NASD of the<br \/>\nterms of the sale of the Securities and (x) the fees and expenses incurred in<br \/>\nconnection with the inclusion of the Securities in the Nasdaq National Market.<\/p>\n<p>         (b) Expenses of the Selling Shareholders. The Selling Shareholders,<br \/>\njointly and severally, will pay all expenses incident to the performance of<br \/>\ntheir respective obligations under, and the consummation of the transactions<br \/>\ncontemplated by the Agreement, including (i) any stamp duties, capital duties<br \/>\nand stock transfer taxes, if any, payable upon the sale of the Securities to the<br \/>\nUnderwriters, and their transfer between the Underwriters pursuant to an<br \/>\nagreement between such Underwriters and (ii) the fees and disbursements of their<br \/>\nrespective counsel and accountants.<\/p>\n<p>         (c) Termination of Agreement. If this Agreement is terminated by the<br \/>\nRepresentatives in accordance with the provisions of Section 5 or Section<br \/>\n9(a)(i) hereof, the Company and the Selling Shareholders shall reimburse the<br \/>\nUnderwriters for all of their out-of-pocket expenses, including the reasonable<br \/>\nfees and disbursements of counsel for the Underwriters.<\/p>\n<p>         (d) Allocation of Expenses. The provisions of this Section shall not<br \/>\naffect any agreement that the Company and the Selling Shareholders may make for<br \/>\nthe sharing of such costs and expenses.<\/p>\n<p>                                       22<br \/>\n   28<br \/>\n         SECTION 5. Conditions of Underwriters&#8217; Obligations. The obligations of<br \/>\nthe several Underwriters hereunder are subject to the accuracy of the<br \/>\nrepresentations and warranties of the Company and the Selling Shareholders<br \/>\ncontained in Section 1 hereof or in certificates of any officer of the Company<br \/>\nor on behalf of any Selling Shareholder delivered pursuant to the provisions<br \/>\nhereof, to the performance by the Company of its covenants and other obligations<br \/>\nhereunder, and to the following further conditions:<\/p>\n<p>                  (a) Effectiveness of Registration Statement. The Registration<br \/>\n         Statement, including any Rule 462(b) Registration Statement, has become<br \/>\n         effective and at Closing Time no stop order suspending the<br \/>\n         effectiveness of the Registration Statement shall have been issued<br \/>\n         under the 1933 Act or proceedings therefor initiated or threatened by<br \/>\n         the Commission, and any request on the part of the Commission for<br \/>\n         additional information shall have been complied with to the reasonable<br \/>\n         satisfaction of counsel to the Underwriters. A prospectus containing<br \/>\n         the Rule 430A Information shall have been filed with the Commission in<br \/>\n         accordance with Rule 424(b) (or a post-effective amendment providing<br \/>\n         such information shall have been filed and declared effective in<br \/>\n         accordance with the requirements of Rule 430A) or, if the Company has<br \/>\n         elected to rely upon Rule 434, a Term Sheet shall have been filed with<br \/>\n         the Commission in accordance with Rule 424(b).<\/p>\n<p>                  (b) Opinion of Counsel for Company. At Closing Time, the<br \/>\n         Representatives shall have received the favorable opinions, dated as of<br \/>\n         Closing Time, of:<\/p>\n<p>                           (i) Hale and Dorr LLP, counsel for the Company, in<br \/>\n         form and substance satisfactory to counsel for the Underwriters,<br \/>\n         together with signed or reproduced copies of such letter for each of<br \/>\n         the other Underwriters to the effect set forth in Exhibit A-1 hereto<br \/>\n         and to such further effect as counsel to the Underwriters may<br \/>\n         reasonably request; and<\/p>\n<p>                           (ii) David A. Graff, general counsel for the Company,<br \/>\n         in form and substance satisfactory to counsel for the Underwriters,<br \/>\n         together with signed or reproduced copies of such letter for each of<br \/>\n         the other Underwriters to the effect set forth in Exhibit A-2 hereto<br \/>\n         and to such further effect as counsel to the Underwriters may<br \/>\n         reasonably request.<\/p>\n<p>                  (c) Opinion of Counsel for the Selling Shareholders. At<br \/>\n         Closing Time, the Representatives shall have received the favorable<br \/>\n         opinion, dated as of Closing Time, of Hale and Dorr LLP, counsel for<br \/>\n         certain of the Selling Shareholders, together with the favorable<br \/>\n         opinion of each counsel for the other Selling Shareholders (which<\/p>\n<p>                                       23<br \/>\n   29<br \/>\n         counsel shall be satisfactory to the Representatives), each in form and<br \/>\n         substance satisfactory to counsel for the Underwriters, together with<br \/>\n         signed or reproduced copies of such letters for each of the other<br \/>\n         Underwriters to the effect set forth in Exhibit A-3 hereto and to such<br \/>\n         other effect as counsel for the Underwriters may reasonably request.<\/p>\n<p>                  (d) Opinion of Counsel for Underwriters. At Closing Time, the<br \/>\n         Representatives shall have received the favorable opinion, dated as of<br \/>\n         Closing Time, of Debevoise &amp; Plimpton, counsel for the Underwriters,<br \/>\n         together with signed or reproduced copies of such letter for each of<br \/>\n         the other Underwriters, in form and substance reasonably satisfactory<br \/>\n         to the Underwriters. In giving such opinion such counsel may rely,<br \/>\n         insofar as such opinion involves factual matters, to the extent they<br \/>\n         deem proper, upon certificates of officers of the Company and<br \/>\n         certificates of public officials.<\/p>\n<p>                  (e) Officers&#8217; Certificate. At Closing Time, there shall not<br \/>\n         have been, since the date hereof or since the respective dates as of<br \/>\n         which information is given in the Prospectus, any material adverse<br \/>\n         change in the condition, financial or otherwise, or in the earnings,<br \/>\n         business affairs or business prospects of the Company, whether or not<br \/>\n         arising in the ordinary course of business, and the Representatives<br \/>\n         shall have received a certificate of the Chief Executive Officer, Chief<br \/>\n         Financial Officer and Chief Operating Officer of the Company, dated as<br \/>\n         of Closing Time, to the effect that (i) there has been no such material<br \/>\n         adverse change, (ii) the representations and warranties in Section 1(a)<br \/>\n         hereof are true and correct with the same force and effect as though<br \/>\n         expressly made at and as of Closing Time, (iii) the Company has<br \/>\n         complied with all agreements and satisfied all conditions on its part<br \/>\n         to be performed or satisfied at or prior to Closing Time, and (iv) no<br \/>\n         stop order suspending the effectiveness of the Registration Statement<br \/>\n         has been issued and no proceedings for that purpose have been<br \/>\n         instituted or are pending or are contemplated by the Commission.<\/p>\n<p>                  (f) Certificate of the Selling Shareholder. At Closing Time,<br \/>\n         the Representatives shall have received a certificate of an<br \/>\n         Attorney-in-Fact on behalf of each Selling Shareholder, dated as of the<br \/>\n         Closing Time, to the effect that (i) the representations and warranties<br \/>\n         of each Selling Shareholder contained in Section 1(b) hereof are true<br \/>\n         and correct in all respects with the same force and effect as though<br \/>\n         expressly made at and as of Closing Time and (ii) each Selling<br \/>\n         Shareholder has complied in all material respects with all agreements<br \/>\n         and all conditions on its part to be performed under the Agreement at<br \/>\n         or prior to Closing Time.<\/p>\n<p>                  (g) Accountant&#8217;s Comfort Letter. At the time of the execution<br \/>\n         of this Agreement, the Representatives shall have received from<br \/>\n         PricewaterhouseCoopers a<\/p>\n<p>                                       24<br \/>\n   30<br \/>\n         letter dated such date, in form and substance satisfactory to the<br \/>\n         Representatives, together with signed or reproduced copies of such<br \/>\n         letter for each of the other Underwriters containing statements and<br \/>\n         information of the type ordinarily included in accountants&#8217; &#8220;comfort<br \/>\n         letters&#8221; to underwriters with respect to the financial statements and<br \/>\n         certain financial information contained in the Registration Statement<br \/>\n         and the Prospectus.<\/p>\n<p>                  (h) Bring-down Comfort Letter. At Closing Time, the<br \/>\n         Representatives shall have received from PricewaterhouseCoopers a<br \/>\n         letter, dated as of Closing Time, to the effect that they reaffirm the<br \/>\n         statements made in the letter furnished pursuant to subsection (g) of<br \/>\n         this Section, except that the specified date referred to shall be a<br \/>\n         date not more than three business days prior to Closing Time.<\/p>\n<p>                  (i) Approval of Listing. At Closing Time, the Securities shall<br \/>\n         have been approved for inclusion in the Nasdaq National Market, subject<br \/>\n         only to official notice of issuance.<\/p>\n<p>                  (j) No Objection. The NASD has confirmed that it has not<br \/>\n         raised any objection with respect to the fairness and reasonableness of<br \/>\n         the underwriting terms and arrangements.<\/p>\n<p>                  (k) Lock-up Agreements. At the date of this Agreement, the<br \/>\n         Representatives shall have received an agreement substantially in the<br \/>\n         form of Exhibit B hereto signed by the persons listed on Schedule D<br \/>\n         hereto.<\/p>\n<p>                  (l) Form W-8 or W-9. At the date of this Agreement, the<br \/>\n         Representatives shall have received form W-8 or W-9, as required,<br \/>\n         signed by each Selling Shareholder.<\/p>\n<p>                  (m) Release of Liens. At Closing Time, the Representatives<br \/>\n         shall have received a duly executed copy of the release, in form and<br \/>\n         substance satisfactory to counsel for the Underwriters, dated Closing<br \/>\n         Time, by The CIT Group\/Commercial Services, Inc. with respect to<br \/>\n         Initial Securities to be sold by Richmont Capital Partners I, L.P. and<br \/>\n         all necessary UCC-3 statements in respect of such Initial Securities,<br \/>\n         each in form and substance satisfactory to counsel for the<br \/>\n         Underwriters.<\/p>\n<p>                  (n) Conditions to Purchase of Option Securities. In the event<br \/>\n         that the Underwriters exercise their option provided in Section 2(b)<br \/>\n         hereof to purchase all or any portion of the Option Securities, the<br \/>\n         representations and warranties of the Company and the Selling<br \/>\n         Shareholders contained herein and the statements in any certificates<br \/>\n         furnished by the Company and the Selling Shareholders hereunder shall<\/p>\n<p>                                       25<br \/>\n   31<br \/>\n         be true and correct as of each Date of Delivery and, at the relevant<br \/>\n         Date of Delivery, the Representatives shall have received:<\/p>\n<p>                  (i) Officers&#8217; Certificate. A certificate, dated such Date of<br \/>\n                  Delivery, of the Chief Executive Officer, Chief Financial<br \/>\n                  Officer and Chief Operating Officer of the Company confirming<br \/>\n                  that the certificate delivered at the Closing Time pursuant to<br \/>\n                  Section 5(e) hereof remains true and correct as of such Date<br \/>\n                  of Delivery.<\/p>\n<p>                  (ii) Certificate of Selling Shareholders. A certificate, dated<br \/>\n                  such Date of Delivery, of an Attorney-in-Fact on behalf of<br \/>\n                  each Selling Shareholder confirming that the certificate<br \/>\n                  delivered at Closing Time pursuant to Section 5(f) remains<br \/>\n                  true and correct as of such Date of Delivery.<\/p>\n<p>                  (iii) Opinion of Counsel for Company. The favorable opinion of<br \/>\n                  Hale and Dorr LLP, counsel for the Company, together with the<br \/>\n                  favorable opinion of David A. Graff, general counsel for the<br \/>\n                  Company, each in form and substance satisfactory to counsel<br \/>\n                  for the Underwriters, dated such Date of Delivery, relating to<br \/>\n                  the Option Securities to be purchased on such Date of Delivery<br \/>\n                  and otherwise to the same effect as the opinion required by<br \/>\n                  Section 5(b) hereof.<\/p>\n<p>                  (iv) Opinion of Counsel for the Selling Shareholders. The<br \/>\n                  favorable opinion of Hale and Dorr LLP, counsel for certain of<br \/>\n                  the Selling Shareholders, together with the favorable opinion<br \/>\n                  of each counsel for the other Selling Shareholders (which<br \/>\n                  counsel shall be satisfactory to the Representatives), each in<br \/>\n                  form and substance satisfactory to counsel for the<br \/>\n                  Underwriters, dated such Date of Delivery, relating to the<br \/>\n                  Option Securities to be purchased on such Date of Delivery and<br \/>\n                  otherwise to the same effect as the opinion required by<br \/>\n                  Section 5(c) hereof.<\/p>\n<p>                  (v) Opinion of Counsel for Underwriters. The favorable opinion<br \/>\n                  of Debevoise &amp; Plimpton, counsel for the Underwriters, dated<br \/>\n                  such Date of Delivery, relating to the Option Securities to be<br \/>\n                  purchased on such Date of Delivery and otherwise to the same<br \/>\n                  effect as the opinion required by Section 5(d) hereof.<\/p>\n<p>                  (vi) Bring-down Comfort Letter. A letter from<br \/>\n                  PricewaterhouseCoopers, in form and substance satisfactory to<br \/>\n                  the Representatives and dated such Date of Delivery,<br \/>\n                  substantially in the same form and substance as the letter<br \/>\n                  furnished to the Representatives pursuant to Section 5(g)<br \/>\n                  hereof, except that<\/p>\n<p>                                       26<br \/>\n   32<br \/>\n                  the &#8220;specified date&#8221; in the letter furnished pursuant to this<br \/>\n                  paragraph shall be a date not more than two days prior to such<br \/>\n                  Date of Delivery.<\/p>\n<p>                  (vii) Release of Liens. At Closing Time, the Representatives<br \/>\n                  shall have received a duly executed copy of the release, in<br \/>\n                  form and substance satisfactory to counsel for the<br \/>\n                  Underwriters, dated Closing Time, by The CIT Group\/Commercial<br \/>\n                  Services, Inc. with respect to Option Securities to be sold by<br \/>\n                  Richmont Capital Partners I, L.P. and all necessary UCC-3<br \/>\n                  statements in respect of such Option Securities, each in form<br \/>\n                  and substance satisfactory to counsel for the Underwriters.<\/p>\n<p>                  (o) Additional Documents. At Closing Time and at each Date of<br \/>\n         Delivery, counsel for the Underwriters shall have been furnished with<br \/>\n         such documents, certificates and opinions as they may require for the<br \/>\n         purpose of enabling them to pass upon the issuance and sale of the<br \/>\n         Securities as herein contemplated, or in order to evidence the accuracy<br \/>\n         of any of the representations or warranties, or the fulfillment of any<br \/>\n         of the conditions, herein contained; and all proceedings taken by the<br \/>\n         Company and the Selling Shareholders in connection with the issuance<br \/>\n         and sale of the Securities as herein contemplated shall be satisfactory<br \/>\n         in form and substance to the Representatives and counsel for the<br \/>\n         Underwriters.<\/p>\n<p>                  (p) Termination of Agreement. If any condition specified in<br \/>\n         this Section shall not have been fulfilled when and as required to be<br \/>\n         fulfilled, this Agreement, or, in the case of any condition to the<br \/>\n         purchase of Option Securities on a Date of Delivery which is after the<br \/>\n         Closing Time, the obligations of the several Underwriters to purchase<br \/>\n         the relevant Option Securities, may be terminated by the<br \/>\n         Representatives by notice to the Company at any time at or prior to<br \/>\n         Closing Time or such Date of Delivery, as the case may be, and such<br \/>\n         termination shall be without liability of any party to any other party<br \/>\n         except as provided in Section 4 and except that Sections 1, 6, 7 and 8<br \/>\n         shall survive any such termination and remain in full force and effect.<\/p>\n<p>         SECTION 6. Indemnification.<\/p>\n<p>         (a) Indemnification of Underwriters. (1) The Company and the Selling<br \/>\nShareholders severally agree to indemnify and hold harmless each Underwriter and<br \/>\neach person, if any, who controls any Underwriter within the meaning of Section<br \/>\n15 of the 1933 Act or Section 20 of the 1934 Act as follows:<\/p>\n<p>                                       27<br \/>\n   33<br \/>\n                  (i) against any and all loss, liability, claim, damage and<br \/>\n         expense whatsoever, as incurred, arising out of any untrue statement or<br \/>\n         alleged untrue statement of a material fact contained in the<br \/>\n         Registration Statement (or any amendment thereto), including the Rule<br \/>\n         430A Information and the Rule 434 Information, if applicable, or the<br \/>\n         omission or alleged omission therefrom of a material fact required to<br \/>\n         be stated therein or necessary to make the statements therein not<br \/>\n         misleading or arising out of any untrue statement or alleged untrue<br \/>\n         statement of a material fact included in any preliminary prospectus or<br \/>\n         the Prospectus (or any amendment or supplement thereto), or the<br \/>\n         omission or alleged omission therefrom of a material fact necessary in<br \/>\n         order to make the statements therein, in the light of the circumstances<br \/>\n         under which they were made, not misleading;<\/p>\n<p>                  (ii) against any and all loss, liability, claim, damage and<br \/>\n         expense what soever, as incurred, to the extent of the aggregate amount<br \/>\n         paid in settlement of any litigation, or any investigation or<br \/>\n         proceeding by any governmental agency or body, commenced or threatened,<br \/>\n         or of any claim whatsoever based upon any such untrue statement or<br \/>\n         omission, or any such alleged untrue statement or omission; provided<br \/>\n         that (subject to Section 6(d) below) any such settlement is effected<br \/>\n         with the written consent of the Company; and<\/p>\n<p>                  (iii) against any and all expense whatsoever, as incurred<br \/>\n         (including the fees and disbursements of counsel chosen by Merrill<br \/>\n         Lynch), reasonably incurred in investigating, preparing or defending<br \/>\n         against any litigation, or any investigation or proceeding by any<br \/>\n         governmental agency or body, commenced or threatened, or any claim<br \/>\n         whatsoever based upon any such untrue statement or omission, or any<br \/>\n         such alleged untrue statement or omission, to the extent that any such<br \/>\n         expense is not paid under (i) or (ii) above;<\/p>\n<p>provided, however, that (x) this indemnity agreement shall not apply to any<br \/>\nloss, liability, claim, damage or expense (a) to the extent arising out of any<br \/>\nuntrue statement or omission or alleged untrue statement or omission made in<br \/>\nreliance upon and in conformity with written information furnished to the<br \/>\nCompany by any Underwriter through the Representatives expressly for use in the<br \/>\nRegistration Statement (or any amendment thereto), including the Rule 430A<br \/>\nInformation and the Rule 434 Information, if applicable, or any preliminary<br \/>\nprospectus or the Prospectus (or any amendment or supplement thereto), (b) with<br \/>\nrespect to any preliminary prospectus, to the extent that the Company shall<br \/>\nsustain the burden of proving (i) that any such loss, claim, expense, damage or<br \/>\nliability of such Underwriter results from the fact that such Underwriter sold<br \/>\nSecurities to a person as to whom there was not sent or given, at or prior to<br \/>\nthe written confirmation of such sale, a copy of the Prospectus (as then amended<br \/>\nor supplemented) in any case where such delivery is required by the 1933 Act,<br \/>\n(ii) that the Company had previously furnished copies thereof in sufficient<br \/>\nquantities to such Underwriter<\/p>\n<p>                                       28<br \/>\n   34<br \/>\nand the loss, claim, expense, damage or liability of such Underwriter results<br \/>\nfrom an untrue statement or omission of a material fact contained in the<br \/>\npreliminary prospectus that was corrected in the Prospectus and (iii) that<br \/>\nsending such Prospectus by the Closing Time to the person or persons asserting<br \/>\nsuch loss, liability, claim, damage or expense would have constituted a defense<br \/>\nto the claim asserted by such person or persons, and (y) that with respect to<br \/>\neach Selling Shareholder other than John E. Chubb and Manuel J. Rivera, the<br \/>\nindemnification provision in this Section 6(a)(1) shall be only with respect to<br \/>\ninformation furnished in writing by or on behalf of such Selling Shareholder<br \/>\nexpressly for use in the Registration Statement (or any amendment thereto),<br \/>\nincluding Rule 430A Information and the Rule 434 Information, if applicable, or<br \/>\nany preliminary prospectus or Prospectus (or any amendment or supplement<br \/>\nthereto); and provided, further, that the aggregate liability of any Selling<br \/>\nShareholder pursuant to this Section 6(a)(1) shall be limited to the net<br \/>\nproceeds received by such Selling Shareholder from the Securities purchased by<br \/>\nthe Underwriters from such Selling Shareholder pursuant to this Agreement; and<br \/>\nprovided further, that no Selling Shareholder shall be liable for any untrue<br \/>\nstatement, omission or alleged omission of any other Selling Shareholder.<\/p>\n<p>         (2) Insofar as this indemnity agreement may permit indemnification for<br \/>\nliabilities under the 1933 Act of any person who is a partner of an Underwriter<br \/>\nor who controls an Underwriter within the meaning of Section 15 of the 1933 Act<br \/>\nor Section 20 of the 1934 Act and who, at the date of this Agreement, is a<br \/>\ndirector or officer of the Company or controls the Company within the meaning of<br \/>\nSection 15 of the 1933 Act or Section 20 of the 1934 Act, such indemnity<br \/>\nagreement is subject to the undertaking of the Company in the Registration<br \/>\nStatement under Item 12.<\/p>\n<p>         (b) Indemnification of Company, Directors and Officers and Selling<br \/>\nShareholders. Each Underwriter severally agrees to indemnify and hold harmless<br \/>\nthe Company, its directors, each of its officers who signed the Registration<br \/>\nStatement, and each person, if any, who controls the Company within the meaning<br \/>\nof Section 15 of the 1933 Act or Section 20 of the 1934 Act and each Selling<br \/>\nShareholder and each person, if any, who controls the Selling Shareholder within<br \/>\nthe meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act against<br \/>\nany and all loss, liability, claim, damage and expense described in the<br \/>\nindemnity contained in subsection (a)(1) of this Section, as incurred, but only<br \/>\nwith respect to untrue statements or omissions, or alleged untrue statements or<br \/>\nomissions, made in the Registration Statement (or any amendment thereto),<br \/>\nincluding the Rule 430A Information and the Rule 434 Information, if applicable,<br \/>\nor any preliminary prospectus or the Prospectus (or any amendment or supplement<br \/>\nthereto) in reliance upon and in conformity with written information furnished<br \/>\nto the Company by such Underwriter through the Representatives expressly for use<br \/>\nin the Registration Statement (or any amendment thereto) or such preliminary<br \/>\nprospectus or the Prospectus (or any amendment or supplement thereto).<\/p>\n<p>                                       29<br \/>\n   35<br \/>\n         (c) Actions against Parties; Notification. Each indemnified party shall<br \/>\ngive notice as promptly as reasonably practicable to each indemnifying party of<br \/>\nany action commenced against it in respect of which indemnity may be sought<br \/>\nhereunder, but failure to so notify an indemnifying party, and any delay in such<br \/>\nnotification, shall not relieve such indemnifying party from any liability<br \/>\nhereunder to the extent it is not materially prejudiced as a result thereof and<br \/>\nin any event shall not relieve it from any liability which it may have otherwise<br \/>\nthan on account of this indemnity agreement. In the case of parties indemnified<br \/>\npursuant to Section 6(a)(1) above, counsel to the indemnified parties shall be<br \/>\nselected by Merrill Lynch, and, in the case of parties indemnified pursuant to<br \/>\nSection 6(b) above, counsel to the indemnified parties shall be selected by the<br \/>\nCompany. An indemnifying party may participate at its own expense in the defense<br \/>\nof any such action; provided, however, that counsel to the indemnifying party<br \/>\nshall not (except with the consent of the indemnified party) also be counsel to<br \/>\nthe indemnified party. In no event shall the indemnifying parties be liable for<br \/>\nfees and expenses of more than one counsel (in addition to any local counsel)<br \/>\nseparate from their own counsel for all indemnified parties in connection with<br \/>\nany one action or separate but similar or related actions in the same<br \/>\njurisdiction arising out of the same general allegations or circumstances. No<br \/>\nindemnifying party shall, without the prior written consent of the indemnified<br \/>\nparties, settle or compromise or consent to the entry of any judgment with<br \/>\nrespect to any litigation, or any investigation or proceeding by any<br \/>\ngovernmental agency or body, commenced or threatened, or any claim whatsoever in<br \/>\nrespect of which indemnification or contribution could be sought under this<br \/>\nSection 6 or Section 7 hereof (whether or not the indemnified parties are actual<br \/>\nor potential parties thereto), unless such settlement, compromise or consent (i)<br \/>\nincludes an unconditional release of each indemnified party from all liability<br \/>\narising out of such litigation, investigation, proceeding or claim and (ii) does<br \/>\nnot include a statement as to or an admission of fault, culpability or a failure<br \/>\nto act by or on behalf of any indemnified party.<\/p>\n<p>         (d) Settlement without Consent if Failure to Reimburse. If at any time<br \/>\nan indemnified party shall have requested an indemnifying party to reimburse the<br \/>\nindemnified party for fees and expenses of counsel, such indemnifying party<br \/>\nagrees that it shall be liable for any settlement of the nature contemplated by<br \/>\nSection 6(a)(1)(ii) effected without its written consent if (i) such settlement<br \/>\nis entered into more than 45 days after receipt by such indemnifying party of<br \/>\nthe aforesaid request, (ii) such indemnifying party shall have received notice<br \/>\nof the terms of such settlement at least 30 days prior to such settlement being<br \/>\nentered into and (iii) such indemnifying party shall not have reimbursed such<br \/>\nindemnified party in accordance with such request prior to the date of such<br \/>\nsettlement.<\/p>\n<p>         (e) Other Agreements with Respect to Indemnification. The provisions of<br \/>\nthis Section shall not affect any agreement among the Company and the Selling<br \/>\nShareholders with respect to indemnification.<\/p>\n<p>                                       30<br \/>\n   36<br \/>\n         SECTION 7. Contribution. If the indemnification provided for in Section<br \/>\n6 hereof is for any reason unavailable to or insufficient to hold harmless an<br \/>\nindemnified party in respect of any losses, liabilities, claims, damages or<br \/>\nexpenses referred to therein, then each indemnifying party shall contribute to<br \/>\nthe aggregate amount of such losses, liabilities, claims, damages and expenses<br \/>\nincurred by such indemnified party, as incurred, (i) in such proportion as is<br \/>\nappropriate to reflect the relative benefits received by the Company and the<br \/>\nSelling Shareholders on the one hand and the Underwriters on the other hand from<br \/>\nthe offering of the Securities pursuant to this Agreement or (ii) if the<br \/>\nallocation provided by clause (i) is not permitted by applicable law, in such<br \/>\nproportion as is appropriate to reflect not only the relative benefits referred<br \/>\nto in clause (i) above but also the relative fault of the Company and the<br \/>\nSelling Shareholders on the one hand and of the Underwriters on the other hand<br \/>\nin connection with the statements or omissions, which resulted in such losses,<br \/>\nliabilities, claims, damages or expenses, as well as any other relevant<br \/>\nequitable considerations.<\/p>\n<p>         The relative benefits received by the Company and the Selling<br \/>\nShareholders on the one hand and the Underwriters on the other hand in<br \/>\nconnection with the offering of the Securities pursuant to this Agreement shall<br \/>\nbe deemed to be in the same respective proportions as the total net proceeds<br \/>\nfrom the offering of the Securities pursuant to this Agreement (before deducting<br \/>\nexpenses) received by the Company and the Selling Shareholders and the total<br \/>\nunderwriting discount received by the Underwriters, in each case as set forth on<br \/>\nthe cover of the Prospectus, or, if Rule 434 is used, the corresponding location<br \/>\non the Term Sheet, bear to the aggregate initial public offering price of the<br \/>\nSecurities as set forth on such cover.<\/p>\n<p>         The relative fault of the Company, the Selling Shareholders and the<br \/>\nUnderwriters shall be determined by reference to, among other things, whether<br \/>\nany such untrue or alleged untrue statement of a material fact or omission or<br \/>\nalleged omission to state a material fact relates to information supplied by the<br \/>\nCompany, the Selling Shareholders or the Underwriters and the parties&#8217; relative<br \/>\nintent, knowledge, access to information and opportunity to correct or prevent<br \/>\nsuch statement or omission.<\/p>\n<p>         The Company, the Selling Shareholders and the Underwriters agree that<br \/>\nit would not be just and equitable if contribution pursuant to this Section 7<br \/>\nwere determined by pro rata allocation (even if the Underwriters were treated as<br \/>\none entity for such purpose) or by any other method of allocation which does not<br \/>\ntake account of the equitable considerations referred to above in this Section<br \/>\n7. The aggregate amount of losses, liabilities, claims, damages and expenses<br \/>\nincurred by an indemnified party and referred to above in this Section 7 shall<br \/>\nbe deemed to include any legal or other expenses reasonably incurred by such<br \/>\nindemnified party in investigating, preparing or defending against any<br \/>\nlitigation, or any investigation or proceeding by any governmental agency or<br \/>\nbody, commenced or threatened, or any claim whatsoever based upon any such<br \/>\nuntrue or alleged untrue statement or omission or alleged omission.<\/p>\n<p>                                       31<br \/>\n   37<br \/>\n         Notwithstanding the provisions of this Section 7, (i) no Underwriter<br \/>\nshall be required to contribute any amount in excess of the amount by which the<br \/>\ntotal price at which the Securities underwritten by it and distributed to the<br \/>\npublic were offered to the public exceeds the amount of any damages which such<br \/>\nUnderwriter has otherwise been required to pay by reason of any such untrue or<br \/>\nalleged untrue statement or omission or alleged omission and (ii) no Selling<br \/>\nShareholder shall be required to contribute any amount in excess of the amount<br \/>\nof the total net proceeds received by such Selling Shareholder from the sale of<br \/>\nSecurities pursuant to this Agreement or on a basis other than as specified in<br \/>\nSection 6(a).<\/p>\n<p>         No person guilty of fraudulent misrepresentation (within the meaning of<br \/>\nSection 11(f) of the 1933 Act) shall be entitled to contribution from any person<br \/>\nwho was not guilty of such fraudulent misrepresentation.<\/p>\n<p>         For purposes of this Section 7, each person, if any, who controls an<br \/>\nUnderwriter within the meaning of Section 15 of the 1933 Act or Section 20 of<br \/>\nthe 1934 Act shall have the same rights to contribution as such Underwriter, and<br \/>\neach director of the Company, each officer of the Company who signed the<br \/>\nRegistration Statement, and each person, if any, who controls the Company or any<br \/>\nSelling Shareholder within the meaning of Section 15 of the 1933 Act or Section<br \/>\n20 of the 1934 Act shall have the same rights to contribution as the Company or<br \/>\nsuch Selling Shareholder, as the case may be. The Underwriters&#8217; respective<br \/>\nobligations to contribute pursuant to this Section 7 are several in proportion<br \/>\nto the number of Initial Securities set forth opposite their respective names in<br \/>\nSchedule A hereto and not joint.<\/p>\n<p>         The provisions of this Section shall not affect any agreement among the<br \/>\nCompany and the Selling Shareholders with respect to contribution.<\/p>\n<p>         SECTION 8. Representations, Warranties and Agreements to Survive<br \/>\nDelivery. All representations, warranties and agreements contained in this<br \/>\nAgreement or in certificates of officers of the Company submitted pursuant<br \/>\nhereto, shall remain operative and in full force and effect, regardless of any<br \/>\ninvestigation made by or on behalf of any Underwriter or controlling person, or<br \/>\nby or on behalf of the Company, and shall survive delivery of the Securities to<br \/>\nthe Underwriters.<\/p>\n<p>         SECTION 9. Termination of Agreement.<\/p>\n<p>         (a) Termination; General. The Representatives may terminate this<br \/>\nAgreement, by notice to the Company and the Selling Shareholders, at any time at<br \/>\nor prior to Closing Time (i) if there has been, since the time of execution of<br \/>\nthis Agreement or since the<\/p>\n<p>                                       32<br \/>\n   38<br \/>\nrespective dates as of which information is given in the Prospectus, any<br \/>\nmaterial adverse change in the condition, financial or otherwise, or in the<br \/>\nearnings, business affairs or business prospects of the Company, whether or not<br \/>\narising in the ordinary course of business, or (ii) if there has occurred any<br \/>\nmaterial adverse change in the financial markets in the United States or the<br \/>\ninternational financial markets, any outbreak of hostilities or escalation<br \/>\nthereof or other calamity or crisis or any change or development involving a<br \/>\nprospective change in national or international political, financial or economic<br \/>\nconditions, in each case the effect of which is such as to make it, in the<br \/>\njudgment of the Representatives, impracticable to market the Securities or to<br \/>\nenforce contracts for the sale of the Securities, or (iii) if trading in any<br \/>\nsecurities of the Company has been suspended or materially limited by the<br \/>\nCommission or the Nasdaq National Market, or if trading generally on the<br \/>\nAmerican Stock Exchange or the New York Stock Exchange or in the Nasdaq National<br \/>\nMarket has been suspended or materially limited, or minimum or maximum prices<br \/>\nfor trading have been fixed, or maximum ranges for prices have been required, by<br \/>\nany of said exchanges or by such system or by order of the Commission, the NASD<br \/>\nor any other governmental authority, or (iv) if a banking moratorium has been<br \/>\ndeclared by either Federal or New York authorities.<\/p>\n<p>         (b) Liabilities. If this Agreement is terminated pursuant to this<br \/>\nSection, such termination shall be without liability of any party to any other<br \/>\nparty except as provided in Section 4 hereof, and provided further that Sections<br \/>\n1, 6, 7 and 8 shall survive such termination and remain in full force and<br \/>\neffect.<\/p>\n<p>         SECTION 10. Default by One or More of the Underwriters. If one or more<br \/>\nof the Underwriters shall fail at Closing Time or a Date of Delivery to purchase<br \/>\nthe Securities which it or they are obligated to purchase under this Agreement<br \/>\n(the &#8220;Defaulted Securities&#8221;), the Representatives shall have the right, within<br \/>\n24 hours thereafter, to make arrangements for one or more of the non-defaulting<br \/>\nUnderwriters, or any other underwriters, to purchase all, but not less than all,<br \/>\nof the Defaulted Securities in such amounts as may be agreed upon and upon the<br \/>\nterms herein set forth; if, however, the Representatives shall not have<br \/>\ncompleted such arrangements within such 24-hour period, then:<\/p>\n<p>                  (a) if the number of Defaulted Securities does not exceed 10%<br \/>\n         of the number of Securities to be purchased on such date, each of the<br \/>\n         non-defaulting Underwriters shall be obligated, severally and not<br \/>\n         jointly, to purchase the full amount thereof in the proportions that<br \/>\n         their respective underwriting obligations hereunder bear to the<br \/>\n         underwriting obligations of all non-defaulting Underwriters, or<\/p>\n<p>                  (b) if the number of Defaulted Securities exceeds 10% of the<br \/>\n         number of Securities to be purchased on such date, this Agreement or,<br \/>\n         with respect to any Date of Delivery which occurs after the Closing<br \/>\n         Time, the obligation of the Underwriters<\/p>\n<p>                                       33<br \/>\n   39<br \/>\n         to purchase and of the Company to sell the Option Securities to be<br \/>\n         purchased and sold on such Date of Delivery shall terminate without<br \/>\n         liability on the part of any non-defaulting Underwriter.<\/p>\n<p>         No action taken pursuant to this Section shall relieve any defaulting<br \/>\nUnderwriter from liability in respect of its default.<\/p>\n<p>         In the event of any such default which does not result in a termination<br \/>\nof this Agreement or, in the case of a Date of Delivery which is after the<br \/>\nClosing Time, which does not result in a termination of the obligation of the<br \/>\nUnderwriters to purchase and the Company to sell the relevant Option Securities,<br \/>\nas the case may be, either (i) the Representatives or (ii) the Company and any<br \/>\nSelling Shareholder shall have the right to postpone Closing Time or the<br \/>\nrelevant Date of Delivery, as the case may be, for a period not exceeding seven<br \/>\ndays in order to effect any required changes in the Registration Statement or<br \/>\nProspectus or in any other documents or arrangements. As used herein, the term<br \/>\n&#8220;Underwriter&#8221; includes any person substituted for an Underwriter under this<br \/>\nSection 10.<\/p>\n<p>         SECTION 11. Default by One or More of the Selling Shareholders or the<br \/>\nCompany.<\/p>\n<p>         (a) If a Selling Shareholder shall fail at Closing Time or at a Date of<br \/>\nDelivery to sell and deliver the number of Securities which such Selling<br \/>\nShareholder or Selling Shareholders are obligated to sell hereunder, and the<br \/>\nremaining Selling Shareholders do not exercise the right hereby granted to<br \/>\nincrease, pro rata or otherwise, the number of Securities to be sold by them<br \/>\nhereunder to the total number to be sold by all Selling Shareholders as set<br \/>\nforth in Schedule B hereto, then the Underwriters may, at option of the<br \/>\nRepresentatives, by notice from the Representatives to the Company and the<br \/>\nnon-defaulting Selling Shareholders, either (a) terminate this Agreement without<br \/>\nany liability on the fault of any non-defaulting party except that the<br \/>\nprovisions of Sections 1, 4, 6, 7 and 8 shall remain in full force and effect or<br \/>\n(b) elect to purchase the Securities which the non-defaulting Selling<br \/>\nShareholders and the Company have agreed to sell hereunder. No action taken<br \/>\npursuant to this Section 11 shall relieve any Selling Shareholder so defaulting<br \/>\nfrom liability, if any, in respect of such default.<\/p>\n<p>         In the event of a default by any Selling Shareholder as referred to in<br \/>\nthis Section 11, each of the Representatives, the Company and the non-defaulting<br \/>\nSelling Shareholders shall have the right to postpone Closing Time or Date of<br \/>\nDelivery for a period not exceeding seven days in order to effect any required<br \/>\nchange in the Registration Statement or Prospectus or in any other documents or<br \/>\narrangements.<\/p>\n<p>                                       34<br \/>\n   40<br \/>\n         (b) If the Company shall fail at Closing Time or at the Date of<br \/>\nDelivery to sell the number of Securities that it is obligated to sell<br \/>\nhereunder, then this Agreement shall terminate without any liability on the part<br \/>\nof any nondefaulting party; provided, however, that the provisions of Sections<br \/>\n1, 4, 6, 7 and 8 shall remain in full force and effect. No action taken pursuant<br \/>\nto this Section shall relieve the Company from liability, if any, in respect of<br \/>\nsuch default.<\/p>\n<p>         SECTION 12. Notices. All notices and other communications hereunder<br \/>\nshall be in writing and shall be deemed to have been duly given if mailed or<br \/>\ntransmitted by any standard form of telecommunication. Notices to the<br \/>\nUnderwriters shall be directed to the Representatives at North Tower, World<br \/>\nFinancial Center, New York, New York 10281-1201, attention of Syndicate<br \/>\nOperations, with a copy to Debevoise &amp; Plimpton, 875 Third Avenue, New York, New<br \/>\nYork, attention of Michael W. Blair; notices to the Company shall be directed to<br \/>\nit at 515 Fifth Avenue, 15th Floor, New York, NY 10175, attention of James L.<br \/>\nStarr, Executive Vice President and Chief Financial Officer, with a copy to Hale<br \/>\n&amp; Dorr LLP, 1455 Pennsylvania Avenue, N.W., Washington, D.C. 20004, attention of<br \/>\nDavid Sylvester and Brent B. Siler; and notices to the Selling Shareholders<br \/>\nshall be directed to the Selling Shareholders, attention of David A. Graff,<br \/>\nLaura K. Eshbaugh and James L. Starr, c\/o the Company at the foregoing address.<\/p>\n<p>         SECTION 13. Parties. This Agreement shall each inure to the benefit of<br \/>\nand be binding upon the Underwriters, the Company and the Selling Shareholders<br \/>\nand their respective successors. Nothing expressed or mentioned in this<br \/>\nAgreement is intended or shall be construed to give any person, firm or<br \/>\ncorporation, other than the Underwriters, the Company and the Selling<br \/>\nShareholders and their respective successors and the controlling persons and<br \/>\nofficers and directors referred to in Sections 6 and 7 and their heirs and legal<br \/>\nrepresentatives, any legal or equitable right, remedy or claim under or in<br \/>\nrespect of this Agreement or any provision herein contained. This Agreement and<br \/>\nall conditions and provisions hereof are intended to be for the sole and<br \/>\nexclusive benefit of the Underwriters, the Company and the Selling Shareholders<br \/>\nand their respective successors, and said controlling persons and officers and<br \/>\ndirectors and their heirs and legal representatives, and for the benefit of no<br \/>\nother person, firm or corporation. No purchaser of Securities from any<br \/>\nUnderwriter shall be deemed to be a successor by reason merely of such purchase.<\/p>\n<p>         SECTION 14. GOVERNING LAW AND TIME. THIS AGREEMENT SHALL BE CONSTRUED<br \/>\nAND ENFORCED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW<br \/>\nYORK (WITHOUT GIVING EFFECT TO ITS PRINCIPLES OR RULES OF CONFLICT OF LAWS TO<br \/>\nTHE EXTENT SUCH<\/p>\n<p>                                       35<br \/>\n   41<br \/>\nPRINCIPLES OR RULES WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAWS OF<br \/>\nANOTHER JURISDICTION). SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.<\/p>\n<p>         SECTION 15. Effect of Headings. The Article and Section headings herein<br \/>\nand the Table of Contents are for convenience only and shall not affect the<br \/>\nconstruction hereof.<\/p>\n<p>                                       36<br \/>\n   42<br \/>\n         If the foregoing is in accordance with your understanding of our<br \/>\nagreement, please sign and return to the Company and the Attorney-in Fact for<br \/>\nthe Selling Shareholders a counterpart hereof, whereupon this instrument, along<br \/>\nwith all counterparts, will become a binding agreement between the Underwriters,<br \/>\nthe Company and the Selling Shareholders in accordance with its terms.<\/p>\n<p>                                    Very truly yours,<\/p>\n<p>                                    EDISON SCHOOLS INC.<\/p>\n<p>                                    By:<br \/>\n                                       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                        Name:<br \/>\n                                        Title:<\/p>\n<p>                                    SELLING SHAREHOLDERS<\/p>\n<p>                                    By:<br \/>\n                                       &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                        Name:<br \/>\n                                        As Attorney-In-Fact acting on behalf<br \/>\n                                        of the Selling Shareholders named in<br \/>\n                                        Schedule B hereto<\/p>\n<p>                                       37<br \/>\n   43<br \/>\nCONFIRMED AND ACCEPTED,<br \/>\n   as of the date first above written:<\/p>\n<p>MERRILL LYNCH &amp; CO.<br \/>\nMERRILL LYNCH, PIERCE, FENNER &amp; SMITH<br \/>\n     INCORPORATED<br \/>\nBANC OF AMERICA SECURITIES LLC,<br \/>\nCREDIT SUISSE FIRST BOSTON CORPORATION,<br \/>\nDONALDSON, LUFKIN &amp; JENRETTE SECURITIES CORPORATION,<br \/>\nJ.P. MORGAN SECURITIES INC.<\/p>\n<p>By:  MERRILL LYNCH, PIERCE, FENNER &amp; SMITH<br \/>\n               INCORPORATED<\/p>\n<p>By:<br \/>\n   &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n       Name:<br \/>\n       Title: Authorized Signatory<\/p>\n<p>For themselves and as Representatives of the<br \/>\nother Underwriters named in Schedule A hereto.<\/p>\n<p>                                       38<br \/>\n   44<br \/>\n                                   SCHEDULE A<\/p>\n<table>\n<caption>\n                                                               Number of<br \/>\n        Name of Underwriter                                Initial Securities<br \/>\n        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-                                &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n<s>                                                        <c><br \/>\nMerrill Lynch, Pierce, Fenner &amp; Smith<br \/>\n           Incorporated                                              &#8211;<\/p>\n<p>Banc of America Securities LLC                                       &#8211;<\/p>\n<p>Credit Suisse First Boston Corporation                               &#8211;<\/p>\n<p>Donaldson, Lufkin &amp; Jenrette Securities<br \/>\n           Corporation                                               &#8211;<\/p>\n<p>J.P. Morgan Securities Inc.                                          &#8211;<\/p>\n<p>                                                                 &#8212;&#8212;&#8212;<br \/>\nTotal                                                            5,000,000<br \/>\n                                                                 =========<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                    Sch A-1<br \/>\n   45<br \/>\n                                   SCHEDULE B<\/p>\n<table>\n<caption>\n                                    Number of Initial        Maximum Number of Option<br \/>\n                                  Securities to be Sold       Securities to Be Sold<br \/>\n                                  &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p><s>                               <c>                        <c><br \/>\nEdison Schools Inc.                     2,500,000                      375,000<\/p>\n<p>Manuel J. Rivera                           50,000                       &#8211; 0 &#8211;<\/p>\n<p>John E. Chubb                              25,000                       &#8211; 0 &#8211;<\/p>\n<p>D2F2 Foundation                           600,000                       &#8211; 0 &#8211;<\/p>\n<p>Nazca Limited Partnership                 128,500                       &#8211; 0 &#8211;<\/p>\n<p>Progressive Investment<br \/>\nCompany, Inc.                             887,740                      375,000<\/p>\n<p>Richmont Capital Partners I,<br \/>\nL.P.                                      200,000                       &#8211; 0 &#8211;<\/p>\n<p>RWJ Education Company I,<br \/>\nLLC                                       500,000                       &#8211; 0 &#8211;<\/p>\n<p>Trustees of Amherst College                40,584                       &#8211; 0 &#8211;<\/p>\n<p>Brearly School Endowment Fund              13,796                       &#8211; 0 &#8211;<\/p>\n<p>Elizabeth H. Mandell Trust for<br \/>\nthe benefit of Peter Mandell                6,898                       &#8211; 0 &#8211;<\/p>\n<p>Elizabeth H. Mandell Trust for<br \/>\nthe benefit of Olivia Mandell               6,898                       &#8211; 0 &#8211;<\/p>\n<p>Tab Products Company Pension<br \/>\nPlan                                       40,584                       &#8211; 0 &#8211;<br \/>\n                                        &#8212;&#8212;&#8212;                      &#8212;&#8212;-<br \/>\n            Total                       5,000,000                      750,000<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                    Sch B-1<br \/>\n   46<br \/>\n                                   SCHEDULE C<\/p>\n<p>                               EDISON SCHOOLS INC.<\/p>\n<p>                        5,000,000 Shares of Common Stock<\/p>\n<p>                           (Par Value $.01 Per Share)<\/p>\n<p>                  I. The public offering price per share for the Securities,<br \/>\n         determined as provided in said Section 2, shall be $-.<\/p>\n<p>                  II. The purchase price per share for the Securities to be paid<br \/>\n         by the several Underwriters shall be $-, being an amount equal to the<br \/>\n         public offering price set forth above less $- per share; provided that<br \/>\n         the purchase price per share for any Option Securities purchased upon<br \/>\n         the exercise of the over-allotment option described in Section 2(b)<br \/>\n         shall be reduced by an amount per share equal to any dividends or<br \/>\n         distributions declared by the Company and payable on the Initial<br \/>\n         Securities but not payable on the Option Securities.<\/p>\n<p>                                    Sch C-1<br \/>\n   47<br \/>\n                                   SCHEDULE D<\/p>\n<p>                          List of persons and entities<br \/>\n                               subject to lock-up<\/p>\n<p>H. Christopher Whittle<br \/>\nBenno C. Schmidt, Jr.<br \/>\nChristopher D. Cerf<br \/>\nJames L. Starr<br \/>\nJohn Chubb, Ph.D<br \/>\nLaura Eshbaugh<br \/>\nReverend Floyd H. Flake<br \/>\nDavid A. Graff<br \/>\nKathleen M. Hamel<br \/>\nTonya G. Hinch<br \/>\nDeborah M. McGriff<br \/>\nManuel J. Rivera<br \/>\nDonald N. Sunderland<br \/>\nVirginia G. Bonker<br \/>\nJohn W. Childs<br \/>\nCharles J. Delaney<br \/>\nRobert Finzi<br \/>\nJohn B. Fullerton<br \/>\nJanet A. Hickey<br \/>\nKlas Hillstrom<br \/>\nJeffrey T. Leeds<br \/>\nWilliam F. Weld<\/p>\n<p>[All other holders of 1% or more of any class<br \/>\nthe Company&#8217;s common stock.]<\/p>\n<p>                                    Sch D-1<br \/>\n   48<br \/>\n                                   SCHEDULE E<\/p>\n<p>                          List of Management Agreements<\/p>\n<p>1.       Feaster-Edison Charter School Agreement between the Company and the<br \/>\n         Chula Vista Elementary School District, California.<\/p>\n<p>2.       Charter School Management Agreement between the Company and the Board<br \/>\n         of Education of the Ravenswood City School District, East Palo Alto,<br \/>\n         California.<\/p>\n<p>3.       Charter School Agreement between the Company and the Board of Education<br \/>\n         of the Fresno Unified School District, California.<\/p>\n<p>4.       Charter School Management Agreement between the Company and the Board<br \/>\n         of Education of the Napa Valley Unified School District, California.<\/p>\n<p>5.       Charter School Management Agreement between the Company and the Board<br \/>\n         of Education of the San Francisco Unified School District, California.<\/p>\n<p>6.       Charter School Management Agreement between the Company and the Board<br \/>\n         of Education of the West Covina Unified School District, California.<\/p>\n<p>7.       Agreement between the Company and the Long Beach Unified School<br \/>\n         District, Long Beach, California.<\/p>\n<p>8.       Agreement between the Company and the Board of Education of the Academy<br \/>\n         School District, Colorado Springs, Colorado.<\/p>\n<p>9.       Modification Agreement between the Company and the Board of Education<br \/>\n         of the Academy School District, Colorado.<\/p>\n<p>10.      Colorado Springs Charter School Management Agreement between the<br \/>\n         Company and Colorado Springs School District No. 11, Colorado.<\/p>\n<p>11.      Third Amendment of the Colorado Springs Charter School Management<br \/>\n         Agreement between the Company and Colorado Springs School District No.<br \/>\n         11, Colorado.<\/p>\n<p>12.      Denver-Edison Charter School Management Agreement between the Company<br \/>\n         and the Denver-Edison Charter School, Colorado.<\/p>\n<p>                                    Sch E-1<br \/>\n   49<br \/>\n13.      Agreement between the Company and the Governing Board of Area<br \/>\n         Cooperative Educational Services, Hamden, Connecticut.<\/p>\n<p>14.      Agreement between the Company and the Thomas A. Edison Charter School<br \/>\n         of Wilmington, Inc., Wilmington, Delaware.<\/p>\n<p>15.      Agreement between the Company and the Friendship Public Charter School,<br \/>\n         Inc., Washington, D.C.<\/p>\n<p>16.      Agreement among the Company, the Dade County Public Schools and the<br \/>\n         United Teachers of Dade County, Florida.<\/p>\n<p>17.      Agreement between the Company and the Bibb County School District,<br \/>\n         Macon, Georgia.<\/p>\n<p>18.      Agreement between the Company and the Drew Charter School, Inc.,<br \/>\n         Atlanta, Georgia.<\/p>\n<p>19.      Agreement between the Company and the Board of Education of the Peoria<br \/>\n         Public Schools, Peoria, Illinois.<\/p>\n<p>20.      Agreement between the Company and the Board of Education of the<br \/>\n         Springfield Public Schools, Springfield, Illinois.<\/p>\n<p>21.      Agreement between Company and the Chicago Charter School Foundation,<br \/>\n         Chicago, Illinois.<\/p>\n<p>22.      Agreement between the Company and the Davenport Community School<br \/>\n         District, Davenport, Iowa.<\/p>\n<p>23.      Agreement between the Company and Wichita School District No. 259,<br \/>\n         Wichita, Kansas.<\/p>\n<p>24.      Addendum #2 to the Agreement between the Company and Wichita School<br \/>\n         District No. 259, Wichita, Kansas.<\/p>\n<p>25.      Agreement between the Company and the Baltimore City Board of<br \/>\n         Education, Baltimore, Maryland.<\/p>\n<p>26.      Management Agreement between the Company and the Boston Renaissance<br \/>\n         Charter School, Boston, Massachusetts.<\/p>\n<p>                                    Sch E-2<br \/>\n   50<br \/>\n27.      Agreement between the Company and Seven Hills Charter School,<br \/>\n         Worcester, Massachusetts.<\/p>\n<p>28.      Agreement between the Company and the Battle Creek Public School<br \/>\n         District, Battle Creek, Michigan.<\/p>\n<p>29.      Management Agreement between the Company and the Edison Public School<br \/>\n         Academy, Detroit, Michigan.<\/p>\n<p>30.      Agreement between the Company and the Detroit Academy of Arts and<br \/>\n         Sciences, Detroit, Michigan.<\/p>\n<p>31.      Agreement between the Company and the YMCA Service Learning Academy,<br \/>\n         Detroit, Michigan.<\/p>\n<p>32.      Agreement between the Company and the Edison Oakland Public School<br \/>\n         Academy, Fernald, Michigan.<\/p>\n<p>33.      Management Agreement between the Company and the Flint School District,<br \/>\n         Flint, Michigan.<\/p>\n<p>34.      First Amended Management Agreement between the Company and the<br \/>\n         Mid-Michigan Public School Academy, Lansing, Michigan.<\/p>\n<p>35.      Management Agreement between the Company and the Board of Education of<br \/>\n         the Mount Clemens Community School District, Mt. Clemens, Michigan.<\/p>\n<p>36.      Agreement between the Company and the Board of Education of the School<br \/>\n         District of the City of Pontiac, Pontiac, Michigan.<\/p>\n<p>37.      Management Agreement between the Company and the Inkster School<br \/>\n         District Board, Inkster, Michigan.<\/p>\n<p>38.      Management Agreement between the Company and the Board of Directors of<br \/>\n         the Duluth Public Schools Academy, Duluth, Minnesota.<\/p>\n<p>39.      Agreement among the Company, Special School District No. 1 (Minneapolis<br \/>\n         Public Schools) and Project for Pride in Living, Inc.<\/p>\n<p>40.      Agreement between the Company and the Westport Community Secondary<br \/>\n         Schools, Kansas City, Missouri.<\/p>\n<p>                                    Sch E-3<br \/>\n   51<br \/>\n41.      Agreement between the Company and the Westport Allen-Edison Village<br \/>\n         Educational School, Kansas City, Missouri.<\/p>\n<p>42.      Management Agreement between the Company and the Granville Charter<br \/>\n         School, Trenton, New Jersey.<\/p>\n<p>43.      Management Agreement between the Company and the Schomburg Charter<br \/>\n         School, Inc., Jersey City, New Jersey.<\/p>\n<p>44.      Agreement between the Company and the Charter School of Science &amp; Technology, Rochester, New York.<\/p>\n<p>45.      Agreement between the Company and the Board of Education of the Wayne<br \/>\n         County Public Schools, Goldsboro, North Carolina.<\/p>\n<p>46.      Agreement between the Company and the Board of Education of the<br \/>\n         Nash-Rocky Mount Public Schools, Whitaker, North Carolina.<\/p>\n<p>47.      Management Agreement between the Company and the Alliance Community<br \/>\n         Schools, Inc., Dayton, Ohio.<\/p>\n<p>48.      Agreement between the Company and the Renaissance Academy-Edison<br \/>\n         Charter School, Phoenixville, Pennsylvania.<\/p>\n<p>49.      Agreement between the Company and the Southwest Independent School<br \/>\n         District, San Antonio, Texas.<\/p>\n<p>50.      Stipulation of Agreement between the Company and the Sherman School<br \/>\n         District, Sherman, Texas.<\/p>\n<p>51.      Agreement between the Company and the Board of Education of the Tyler<br \/>\n         Independent School District, Tyler, Texas.<\/p>\n<p>52.      Agreement between the Company and the Dallas Independent School<br \/>\n         District, Dallas, Texas.<\/p>\n<p>53.      Agreement between the Company and the Milwaukee Urban League Academy of<br \/>\n         Business and Economics Inc., Milwaukee, Wisconsin.<\/p>\n<p>54.      Agreement between the Company and Milwaukee Science Education<br \/>\n         Consortium, Milwaukee, Wisconsin.<\/p>\n<p>                                    Sch E-4<br \/>\n   52<br \/>\n                                                                     Exhibit A-1<\/p>\n<p>                      FORM OF OPINION OF COMPANY&#8217;S COUNSEL<br \/>\n                           TO BE DELIVERED PURSUANT TO<br \/>\n                                 SECTION 5(b)(i)<\/p>\n<p>                  (i) The Company has been duly incorporated and is validly<br \/>\n         existing as a corporation in good standing under the laws of the State<br \/>\n         of Delaware.<\/p>\n<p>                  (ii) The Company has corporate power and authority to own,<br \/>\n         lease and operate its properties and to conduct its business as<br \/>\n         described in the Prospectus and to enter into and perform its<br \/>\n         obligations under the Purchase Agreement.<\/p>\n<p>                  (iii) The Company is duly qualified as a foreign corporation<br \/>\n         to transact business and is in good standing in each jurisdiction<br \/>\n         listed on Schedule A to this opinion.<\/p>\n<p>                  (iv) The authorized, issued and outstanding capital stock of<br \/>\n         record of the Company (a) was, as of March 31, 2000, as set forth in<br \/>\n         the Prospectus in the column entitled &#8220;Actual&#8221; under the caption<br \/>\n         &#8220;Capitalization&#8221; and (b) after giving effect to the transactions<br \/>\n         contemplated by this Agreement and the Registration Statement, will be<br \/>\n         as set forth in the Prospectus in the column entitled &#8220;As Adjusted&#8221;<br \/>\n         under the caption &#8220;Capitalization&#8221; (except for issuances subsequent to<br \/>\n         March 31, 2000, if any, pursuant to reservations, agreements or<br \/>\n         employee benefit plans referred to in the Prospectus or pursuant to the<br \/>\n         exercise of convertible securities, options or warrants referred to in<br \/>\n         the Prospectus); the shares of issued and outstanding capital stock of<br \/>\n         the Company, including the Securities to be purchased by the<br \/>\n         Underwriters from the Selling Shareholders, have been duly authorized<br \/>\n         and validly issued and are fully paid and non-assessable; and none of<br \/>\n         the outstanding shares of capital stock of record of the Company was<br \/>\n         issued in violation of any preemptive or other similar rights of any<br \/>\n         securityholder of the Company arising under (a) the Company&#8217;s<br \/>\n         certificate of incorporation or by-laws (as in effect from time to<br \/>\n         time), (b) any contract, indenture, mortgage, loan agreement, note,<br \/>\n         lease or other agreement or instrument filed as an exhibit to the<br \/>\n         Registration Statement, (c) the Delaware General Corporation Law or (d)<br \/>\n         to our knowledge, arising otherwise.<\/p>\n<p>                  (v) The Securities to be purchased by the Underwriters from<br \/>\n         the Company have been duly authorized for issuance and sale to the<br \/>\n         Underwriters pursuant to the Purchase Agreement and, when issued and<br \/>\n         delivered by the Company pursuant to the Purchase Agreement against<br \/>\n         payment of the consideration<\/p>\n<p>                                     A-1-1<br \/>\n   53<br \/>\n         set forth in the Purchase Agreement, will be validly issued and fully<br \/>\n         paid and non-assessable and no holder of the Securities is or will be<br \/>\n         subject to personal liability by reason of being such a holder.<\/p>\n<p>                  (vi) The issuance of the Securities by the Company and the<br \/>\n         sale of the Securities by the Selling Shareholders is not subject to<br \/>\n         any preemptive or other similar rights of any securityholder of the<br \/>\n         Company arising under (a) the Company&#8217;s certificate of incorporation or<br \/>\n         by-laws (as in effect on the date hereof), (b) any contract, indenture,<br \/>\n         mortgage, loan agreement, note, lease or other agreement or instrument<br \/>\n         filed as an exhibit to the Registration Statement, (c) the Delaware<br \/>\n         General Corporation Law or (d) to our knowledge, arising otherwise.<\/p>\n<p>                  (vii) To our knowledge, the Company does not have any<br \/>\n         subsidiaries, and, to our knowledge, the Company does not have any<br \/>\n         equity investments in other companies, except the Company&#8217;s interest in<br \/>\n         APEX.<\/p>\n<p>                  (viii) The Purchase Agreement has been duly authorized,<br \/>\n         executed and delivered by the Company.<\/p>\n<p>                  (ix) The Registration Statement, including any Rule 462(b)<br \/>\n         Registration Statement, has been declared effective under the 1933 Act;<br \/>\n         any required filing of the Prospectus pursuant to Rule 424(b) has been<br \/>\n         made in the manner and within the time period required by Rule 424(b);<br \/>\n         and, to our knowledge, no stop order suspending the effectiveness of<br \/>\n         the Registration Statement or any Rule 462(b) Registration Statement<br \/>\n         has been issued under the 1933 Act and no proceedings for that purpose<br \/>\n         have been instituted or are pending or threatened by the Commission.<\/p>\n<p>                  (x) The Registration Statement, including any Rule 462(b)<br \/>\n         Registration Statement, the Rule 430A Information and the Rule 434<br \/>\n         Information, as applicable, the Prospectus and each amendment or<br \/>\n         supplement to the Registration Statement and the Prospectus as of their<br \/>\n         respective effective or issue dates (other than the financial<br \/>\n         statements and supporting schedules included therein or omitted<br \/>\n         therefrom, as to which we need express no opinion) complied as to form<br \/>\n         in all material respects with the requirements of the 1933 Act and the<br \/>\n         1933 Act Regulations.<\/p>\n<p>                  (xi) If Rule 434 has been relied upon, the Prospectus was not<br \/>\n         &#8220;materially different,&#8221; as such term is used in Rule 434, from the<br \/>\n         prospectus included in the Registration Statement at the time it became<br \/>\n         effective.<\/p>\n<p>                                     A-1-2<br \/>\n   54<br \/>\n                  (xii) The form of certificate used to evidence the Common<br \/>\n         Stock complies in all material respects with all applicable statutory<br \/>\n         requirements, with any applicable requirements of the charter and<br \/>\n         by-laws of the Company and the requirements of the Nasdaq National<br \/>\n         Market.<\/p>\n<p>                  (xiii) To our knowledge, there is not pending or threatened<br \/>\n         any action, suit, proceeding, inquiry or investigation, to which the<br \/>\n         Company or any school operated by the Company is a party, or to which<br \/>\n         the property of the Company or any school operated by the Company is<br \/>\n         subject, before or brought by any court or governmental agency or body,<br \/>\n         domestic or foreign, which might reasonably be expected to result in a<br \/>\n         Material Adverse Effect, or which might reasonably be expected to<br \/>\n         materially and adversely affect the consummation of the transactions<br \/>\n         contemplated in the Purchase Agreement or the performance by the<br \/>\n         Company of its obligations thereunder.<\/p>\n<p>                  (xiv) The information in the Prospectus under &#8220;Summary &#8211;<br \/>\n         Description of Capital Stock&#8221;, &#8220;Description of Capital Stock&#8221;, and in<br \/>\n         the first paragraph and the first and third sentences in the second<br \/>\n         paragraph under &#8220;Management-Election of Directors&#8221;, the last sentence<br \/>\n         of &#8220;Management-Executive Officers and Directors&#8221;, and in the<br \/>\n         Registration Statement in the first two paragraphs under Item 14, to<br \/>\n         the extent that it constitutes matters of law, summaries of legal<br \/>\n         matters, the Company&#8217;s charter and bylaws or legal proceedings, or<br \/>\n         legal conclusions, has been reviewed by us and is correct in all<br \/>\n         material respects.<\/p>\n<p>                  (xv) To our knowledge, there are no statutes or regulations<br \/>\n         that are required to be described in the Prospectus that are not<br \/>\n         described as required.<\/p>\n<p>                  (xvi) To our knowledge, there are no franchises, contracts,<br \/>\n         indentures, mortgages, loan agreements, notes, leases or other<br \/>\n         instruments required to be described or referred to in the Registration<br \/>\n         Statement or to be filed as exhibits thereto other than those described<br \/>\n         or referred to therein or filed or incorporated by reference as<br \/>\n         exhibits thereto.<\/p>\n<p>                  (xvii) To our knowledge, the Company is not in violation of<br \/>\n         its charter or by-laws.<\/p>\n<p>                  (xviii) No filing with, or authorization, approval, consent,<br \/>\n         license, order, registration, qualification or decree of, any court or<br \/>\n         governmental authority or agency, domestic or foreign (other than under<br \/>\n         the 1933 Act and the 1933 Act Regulations, which have been obtained, or<br \/>\n         as may be required under the securities or blue sky laws of the various<br \/>\n         states, as to which we need express no opinion) is<\/p>\n<p>                                     A-1-3<br \/>\n   55<br \/>\n         necessary or required in connection with the due authorization,<br \/>\n         execution and delivery of the Purchase Agreement or for the offering,<br \/>\n         issuance, sale or delivery of the Securities.<\/p>\n<p>                  (xix) The execution, delivery and performance of the Purchase<br \/>\n         Agreement and the consummation of the transactions contemplated in the<br \/>\n         Purchase Agreement and in the Registration Statement (including the<br \/>\n         issuance and sale of the Securities) and compliance by the Company with<br \/>\n         its obligations under the Purchase Agreement do not and will not,<br \/>\n         whether with or without the giving of notice or lapse of time or both,<br \/>\n         conflict with or constitute a breach of, or default or Repayment Event<br \/>\n         (as defined in Section 1(a)(x) of the Purchase Agreement) under or<br \/>\n         result in the creation or imposition of any lien, charge or encumbrance<br \/>\n         upon any property or assets of the Company pursuant to any contract,<br \/>\n         indenture, mortgage, deed of trust, loan or credit agreement, note,<br \/>\n         lease or any other agreement or instrument filed as an exhibit to the<br \/>\n         Registration Statement (except for such conflicts, breaches or defaults<br \/>\n         or liens, charges or encumbrances that could not reasonably be expected<br \/>\n         to have a Material Adverse Effect), nor will such action result in any<br \/>\n         violation of the provisions of the charter or by-laws of the Company,<br \/>\n         applicable law, statute, rule or regulation or any judgment, order,<br \/>\n         writ or decree specifically naming the Company, known to us, of any<br \/>\n         government, government instrumentality or court, domestic or foreign,<br \/>\n         having jurisdiction over the Company or any of its properties, assets<br \/>\n         or operations.<\/p>\n<p>                  (xx) To our knowledge, except as described in the Prospectus<br \/>\n         under the caption &#8220;Description of Capital Stock&#8211;Registration Rights&#8221;<br \/>\n         there are no persons with registration rights or other similar rights<br \/>\n         to have any securities registered pursuant to the Registration<br \/>\n         Statement or otherwise registered by the Company under the 1933 Act.<\/p>\n<p>                  (xxi) To our knowledge, except as disclosed in the Prospectus,<br \/>\n         there are no outstanding options to purchase, or any preemptive rights<br \/>\n         or other rights to subscribe for or to purchase, any securities or<br \/>\n         obligations convertible into, or any contracts or commitments to issue<br \/>\n         or sell, shares of the Company&#8217;s capital stock or any such options,<br \/>\n         rights, convertible securities or obligations.<\/p>\n<p>                  (xxii) The Company is not an &#8220;investment company&#8221; or an entity<br \/>\n         &#8220;controlled&#8221; by an &#8220;investment company,&#8221; as such terms are defined in<br \/>\n         the 1940 Act.<\/p>\n<p>                  In connection with the preparation of the Registration<br \/>\n         Statement and the Prospectus, we have participated in conferences with<br \/>\n         officers and representatives of<\/p>\n<p>                                     A-1-4<br \/>\n   56<br \/>\n         the Company, counsel for the Underwriters and independent accountants<br \/>\n         of the Company, at which conferences we made inquiries of such persons<br \/>\n         and others and discussed the contents of the Registration Statement and<br \/>\n         the Prospectus. While the limitations inherent in the independent<br \/>\n         verification of factual matters and the character of determinations<br \/>\n         involved in the registration process are such that we are not passing<br \/>\n         upon and do not assume any responsibility for the accuracy,<br \/>\n         completeness or fairness of the statements contained in the<br \/>\n         Registration Statement or the Prospectus, subject to the foregoing and<br \/>\n         based on such participation, inquiries and discussions, nothing has<br \/>\n         come to our attention that would lead us to believe that the<br \/>\n         Registration Statement or any amendment thereto, including the Rule<br \/>\n         430A Information and Rule 434 Information (if applicable) (except for<br \/>\n         financial statements and schedules and other financial data included<br \/>\n         therein or omitted therefrom and percentages derived from financial<br \/>\n         data included therein, as to which we need make no statement), at the<br \/>\n         time such Registration Statement or any such amendment became<br \/>\n         effective, contained an untrue statement of a material fact or omitted<br \/>\n         to state a material fact required to be stated therein or necessary to<br \/>\n         make the statements therein not misleading or that the Prospectus or<br \/>\n         any amendment or supplement thereto (except for financial statements<br \/>\n         and schedules and other financial data included therein or omitted<br \/>\n         therefrom and percentages derived from financial data included therein,<br \/>\n         as to which we need make no statement), as of their respective dates or<br \/>\n         at the Closing Time, included or includes an untrue statement of a<br \/>\n         material fact or omitted or omits to state a material fact necessary in<br \/>\n         order to make the statements therein, in the light of the circumstances<br \/>\n         under which they were made, not misleading.<\/p>\n<p>                  Such opinion shall not state that it is to be governed or<br \/>\n         qualified by, or that it is otherwise subject to, any treatise, written<br \/>\n         policy or other document relating to legal opinions, including, without<br \/>\n         limitation, the Legal Opinion Accord of the ABA Section of Business Law<br \/>\n         (1991).<\/p>\n<p>                                     A-1-5<br \/>\n   57<br \/>\n                                                                     Exhibit A-2<\/p>\n<p>                     FORM OF OPINION OF THE GENERAL COUNSEL<br \/>\n                         FOR THE COMPANY TO BE DELIVERED<br \/>\n                          PURSUANT TO SECTION 5(b)(ii)<\/p>\n<p>                  (i) All descriptions in the Prospectuses of and references in<br \/>\n         the Prospectus to franchises, contracts, indentures, mortgages, loan<br \/>\n         agreements, notes, leases or other instruments or documents or<br \/>\n         transactions to which the Company is or was a party are accurate in all<br \/>\n         material respects;<\/p>\n<p>                  (ii) To my knowledge, no default by the Company exists in the<br \/>\n         due performance or observance of any material obligation, agreement,<br \/>\n         covenant or condition contained in any Management Agreement or any<br \/>\n         other contract, indenture, mortgage, loan agreement, note, lease or<br \/>\n         other agreement or instrument that is described or referred to in the<br \/>\n         Registration Statement or the Prospectus or filed or incorporated by<br \/>\n         reference as an exhibit to the Registration Statement.<\/p>\n<p>                  (iii) The execution, delivery and performance of the Purchase<br \/>\n         Agreement and the consummation of the transactions contemplated in the<br \/>\n         Purchase Agreement and in the Registration Statement (including the<br \/>\n         issuance and sale of the Securities, and compliance by the Company with<br \/>\n         its obligations under the Purchase Agreement do not and will not,<br \/>\n         whether with or without the giving of notice or lapse of time or both,<br \/>\n         conflict with or constitute a breach of, or default or Repayment Event<br \/>\n         (as defined in Section 1(a)(x) of the Purchase Agreement) under or<br \/>\n         result in the creation or imposition of any lien, charge or encumbrance<br \/>\n         upon any property or assets of the Company pursuant to any Management<br \/>\n         Agreement or other contract, indenture, mortgage, deed of trust, loan<br \/>\n         or credit agreement, note, lease or any other agreement or instrument<br \/>\n         filed as an exhibit to the Registration Statement or otherwise known to<br \/>\n         me (except for such conflicts, breaches or defaults or liens, charges<br \/>\n         or encumbrances that could not reasonably be expected to have a<br \/>\n         Material Adverse Effect), nor will such action result in any violation<br \/>\n         of the provisions of the charter or by-laws of the Company, applicable<br \/>\n         law, statute, rule, regulation, judgment, order, writ or decree, known<br \/>\n         to me, of any government, government instrumentality or court, domestic<br \/>\n         or foreign, having jurisdiction over the Company or any of its<br \/>\n         properties, assets or operations.<\/p>\n<p>                  (iv) The execution, delivery and performance of the Purchase<br \/>\n         Agreement and the consummation of the transactions contemplated in the<br \/>\n         Purchase Agreement and in the Registration Statement (including the<br \/>\n         issuance and sale of the Securities, and compliance by the Company with<br \/>\n         its obligations under the Purchase Agreement do not and will not result<br \/>\n         in any violation of the ESEA, the IDEA, including any<\/p>\n<p>                                     A-2-1<br \/>\n   58<br \/>\n         rules or regulations promulgated pursuant to such laws, or any other<br \/>\n         federal, state or local statute pertaining to the authorization to<br \/>\n         operate public schools or eligibility for funding under federal, state<br \/>\n         or local programs.<\/p>\n<p>                  (v) No filing with, or authorization, approval, consent,<br \/>\n         license, order, registration, qualification or decree of, the USDE or,<br \/>\n         to my knowledge, any state agency under any state statute pertaining to<br \/>\n         authorization to operate public schools or eligibility for funding<br \/>\n         under federal or state programs is necessary or required in connection<br \/>\n         with the due authorization, execution and delivery of the Purchase<br \/>\n         Agreement or for the offering, issuance, sale or delivery of the<br \/>\n         Securities.<\/p>\n<p>                  (vi) To my knowledge, the Company and each of the schools<br \/>\n         operated by it possess all permits, licenses, approvals, consents and<br \/>\n         other authorizations required, including without limitation<br \/>\n         authorizations required (i) to participate in federal funding programs<br \/>\n         under the ESEA and the IDEA to the extent the Company or such school<br \/>\n         currently receives material funding thereunder, (ii) to operate charter<br \/>\n         schools under state charter statutes, and (iii) to receive funding<br \/>\n         under federal, state or local education laws, statutes, rules,<br \/>\n         regulations, standards, guides and orders to the extent the Company or<br \/>\n         such school currently receives material funding thereunder<br \/>\n         (collectively, &#8220;Governmental Licenses&#8221;), issued by the appropriate<br \/>\n         federal, state or local regulatory agencies or bodies necessary to<br \/>\n         conduct the business now operated by them, except where the failure to<br \/>\n         possess such Governmental Licenses could not reasonably be expected to<br \/>\n         have a material Adverse Effect; the Company and, to my knowledge each<br \/>\n         of the schools operated by it, is in compliance with the terms and<br \/>\n         conditions of all such Governmental Licenses, except where the failure<br \/>\n         so to comply could not, singly or in the aggregate, have a Material<br \/>\n         Adverse Effect; all of the Governmental Licenses are valid and in full<br \/>\n         force and effect, except when the invalidity of such Governmental<br \/>\n         Licenses or the failure of such Governmental Licenses to be in full<br \/>\n         force and effect could not have a Material Adverse Effect; and, to my<br \/>\n         knowledge, the Company has not received any notice of proceedings<br \/>\n         relating to the revocation or modification of any such Governmental<br \/>\n         Licenses which, singly or in the aggregate, if the subject of an<br \/>\n         unfavorable decision, ruling or finding, could result in a Material<br \/>\n         Adverse Effect.<\/p>\n<p>                  (vii) To my knowledge, there is not pending or threatened any<br \/>\n         action, suit, proceeding, inquiry or investigation, to which the<br \/>\n         Company or any school operated by the Company is a party, or to which<br \/>\n         the property of the Company or any school operated by the Company is<br \/>\n         subject, before or brought by the USDE, the DOJ, the EEOC, state and<br \/>\n         local educational agencies (including school boards and public school<br \/>\n         districts) or charter school boards which might reasonably be expected<br \/>\n         to result in a Material Adverse Effect, or which might reasonably be<\/p>\n<p>                                     A-2-2<br \/>\n   59<br \/>\n         expected to materially and adversely affect the consummation of the<br \/>\n         transactions contemplated in the Purchase Agreement or the performance<br \/>\n         by the Company of its obligations thereunder.<\/p>\n<p>                  (viii) To my knowledge, the Company and each of the schools<br \/>\n         operated by the Company are in compliance with all applicable education<br \/>\n         laws, statutes, rules, regulations, standards, guides or orders<br \/>\n         administered, issued or implemented by any federal, state or local<br \/>\n         government or any agency or subdivision of any of the foregoing,<br \/>\n         including, without limitation, the USDE, the DOJ, the EEOC, state and<br \/>\n         local education agencies (including school boards and public school<br \/>\n         districts) or charter school boards, except where the failure to be in<br \/>\n         compliance would not reasonably be expected to have a Material Adverse<br \/>\n         Effect. To my knowledge, neither the Company nor any of the schools<br \/>\n         operated by it has been advised that either the Company or any of the<br \/>\n         schools operated by the Company is not conducting business in<br \/>\n         compliance with all applicable federal, state and local education laws,<br \/>\n         statutes, rules, regulations, standards, guides and orders, except<br \/>\n         where failure to be so in compliance could not reasonably be expected<br \/>\n         to have a Material Adverse Effect.<\/p>\n<p>                  (ix) The information in the Prospectus under &#8220;Risk<br \/>\n         Factors&#8211;Risks Related to Governmental Funding and Regulation of the<br \/>\n         Education Industry&#8221;, &#8220;Business&#8211;Government Laws and Regulations&#8221;, to<br \/>\n         the extent that it constitutes matters of law, summaries of legal<br \/>\n         matters, or legal conclusions (collectively, &#8220;Education Matters&#8221;), has<br \/>\n         been reviewed by me and is correct in all material respects.<\/p>\n<p>                  (x) Neither the Company, nor any of the schools operated by<br \/>\n         the Company is subject to any requirements of, or regulation under, the<br \/>\n         Higher Education Act of 1965, as amended.<\/p>\n<p>                  Nothing has come to my attention that would lead me to believe<br \/>\n         that the Registration Statement or any amendment thereto, including the<br \/>\n         Rule 430A Information and Rule 434 Information (if applicable) (except<br \/>\n         for financial statements and schedules and other financial data<br \/>\n         included therein or omitted therefrom and percentages derived from<br \/>\n         financial data included therein, as to which I need make no statement),<br \/>\n         at the time such Registration Statement or any such amendment became<br \/>\n         effective, contained an untrue statement of a material fact or omitted<br \/>\n         to state a material fact required to be stated therein or necessary to<br \/>\n         make the statements therein not misleading or that the Prospectus or<br \/>\n         any amendment or supplement thereto (except for financial statements<br \/>\n         and schedules and other financial data included therein or omitted<br \/>\n         therefrom and percentages derived from<\/p>\n<p>                                     A-2-3<br \/>\n   60<br \/>\n         financial data included therein, as to which we need make no<br \/>\n         statement), as of their respective dates or at the Closing Time,<br \/>\n         included or includes an untrue statement of a material fact or omitted<br \/>\n         or omits to state a material fact necessary in order to make the<br \/>\n         statements therein, in the light of the circumstances under which they<br \/>\n         were made, not misleading.<\/p>\n<p>                  Such opinion shall not state that it is to be governed or<br \/>\n         qualified by, or that it is otherwise subject to, any treatise, written<br \/>\n         policy or other document relating to legal opinions, including, without<br \/>\n         limitation, the Legal Opinion Accord of the ABA Section of Business Law<br \/>\n         (1991).<\/p>\n<p>                                     A-2-4<br \/>\n   61<br \/>\n                                                                     Exhibit A-3<\/p>\n<p>                       FORM OF OPINION OF COUNSEL FOR THE<br \/>\n                             SELLING SHAREHOLDER(S)<br \/>\n                    TO BE DELIVERED PURSUANT TO SECTION 5(c)<\/p>\n<p>         (i) No filing with, or consent, approval, authorization, license,<br \/>\norder, registration, qualification or decree of, any court or governmental<br \/>\nauthority or agency, domestic or foreign, (other than the issuance of the order<br \/>\nof the Commission declaring the Registration Statement effective and such<br \/>\nauthorizations, approvals or consents as may be necessary under state securities<br \/>\nlaws, as to which [I][we] need express no opinion) is necessary or required to<br \/>\nbe obtained by the Selling Shareholder(s) for the performance by [each\/the]<br \/>\nSelling Shareholder of its obligations under the Purchase Agreement or in the<br \/>\nPower of Attorney and Custody Agreement, or in connection with the offer, sale<br \/>\nor delivery of the Securities.<\/p>\n<p>         (ii) [Each\/The] Power of Attorney and Custody Agreement has been duly<br \/>\nexecuted and delivered by the [respective] Selling Shareholder(s) [named<br \/>\ntherein] and constitutes the legal, valid and binding agreement of [such\/the]<br \/>\nSelling Shareholder. The Purchase Agreement has been duly authorized, executed<br \/>\nand delivered by or on behalf of [each\/the] Selling Shareholder.<\/p>\n<p>         (iii) [Each\/The] Attorney-in-Fact has been duly authorized by the<br \/>\nSelling Shareholder(s) to deliver the Securities on behalf of the Selling<br \/>\nShareholder(s) in accordance with the terms of the Purchase Agreement.<\/p>\n<p>         (iv) The execution, delivery and performance of the Purchase Agreement<br \/>\nand the Power of Attorney and Custody Agreement and the sale and delivery of the<br \/>\nSecurities and the consummation of the transactions contemplated in the Purchase<br \/>\nAgreement and in the Registration Statement and compliance by the Selling<br \/>\nShareholder(s) with its obligations under the Purchase Agreement have been duly<br \/>\nauthorized by all necessary action on the part of the Selling Shareholder(s) and<br \/>\ndo not and will not, whether with or without the giving of notice or passage of<br \/>\ntime or both, conflict with or constitute a breach of, or default under or<br \/>\nresult in the creation or imposition of any tax, lien, charge or encumbrance<br \/>\nupon the Securities or any property or assets of the Selling Shareholder(s)<br \/>\npursuant to, any contract, indenture, mortgage, deed of trust, loan or credit<br \/>\nagreement, note, license, lease or other instrument or agreement to which<br \/>\n[any\/the] Selling Shareholder is a party or by which [his\/her\/it\/they] may be<br \/>\nbound, or to which any of the property or assets of the Selling Shareholder(s)<br \/>\nmay be subject nor will such action result in any violation of the provisions of<br \/>\nthe charter or by-laws of the Selling Shareholder(s), if applicable, or any law,<br \/>\nadministrative regulation, judgment or order of any governmental agency or body<br \/>\nor any administrative or court decree having jurisdiction over [such\/the]<br \/>\nSelling Shareholder or any of its properties.<\/p>\n<p>                                     A-3-1<br \/>\n   62<br \/>\n         (v) To the best of [our][my] knowledge, [each\/the] Selling Shareholder<br \/>\nhas valid and marketable title to the Securities to be sold by [such\/the]<br \/>\nSelling Shareholder pursuant to the Purchase Agreement, free and clear of any<br \/>\npledge, lien, security interest, charge, claim, equity or encumbrance of any<br \/>\nkind, and has full right, power and authority to sell, transfer and deliver such<br \/>\nSecurities pursuant to the Purchase Agreement. By delivery of a certificate or<br \/>\ncertificates therefor [such\/the] Selling Shareholder will transfer to the<br \/>\nUnderwriters who have purchased such Securities pursuant to the Purchase<br \/>\nAgreement (assuming each such Underwriter has no notice of any adverse claim, as<br \/>\ndefined in Uniform Commercial Code as adopted in the State of New York (the<br \/>\n&#8220;NYUCC&#8221;)), valid and marketable title to such Securities, free and clear of any<br \/>\nadverse claim (as defined in the NYUCC), pledge, lien, security interest,<br \/>\ncharge, claim, equity or encumbrance of any kind.<\/p>\n<p>         Such opinion shall not state that it is to be governed or qualified by,<br \/>\nor that it is otherwise subject to, any treatise, written policy or other<br \/>\ndocument relating to legal opinions, including, without limitation, the Legal<br \/>\nOpinion Accord of the ABA Section of Business Law (1991).<\/p>\n<p>                                     A-3-2<br \/>\n   63<br \/>\n                                                                       Exhibit B<\/p>\n<p>        [Form of lock-up from directors, officers or other stockholders]<\/p>\n<p>                                                              _________ __, 2000<\/p>\n<p>MERRILL LYNCH &amp; CO.<br \/>\nMerrill Lynch, Pierce, Fenner &amp; Smith<br \/>\n    Incorporated,<br \/>\nBanc of America Securities LLC<br \/>\nCredit Suisse First Boston Corporation<br \/>\nDonaldson, Lufkin &amp; Jenrette Securities Corporation<br \/>\nJ.P. Morgan Securities Inc.<br \/>\n    as Representatives of the several<br \/>\n    Underwriters to be named in the<br \/>\n    within-mentioned Purchase Agreement<br \/>\nc\/o Merrill Lynch &amp; Co.<br \/>\nMerrill Lynch, Pierce, Fenner &amp; Smith<br \/>\n    Incorporated<br \/>\nNorth Tower<br \/>\nWorld Financial Center<br \/>\nNew York, New York  10281-1209<\/p>\n<p>         Re:   Proposed Public Offering by Edison Schools Inc.<\/p>\n<p>Dear Sirs:<\/p>\n<p>         The undersigned, a stockholder, officer or director of Edison Schools<br \/>\nInc., a Delaware corporation (the &#8220;Company&#8221;), understands that Merrill Lynch &amp; Co., Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated (&#8220;Merrill Lynch&#8221;) and<br \/>\nBanc of America Securities LLC, Credit Suisse First Boston Corporation,<br \/>\nDonaldson, Lufkin &amp; Jenrette Securities Corporation, J.P. Morgan Securities Inc.<br \/>\npropose to enter into a Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with the<br \/>\nCompany and the selling shareholders listed in the Purchase Agreement (the<br \/>\n&#8220;Selling Shareholders&#8221;) providing for the public offering of shares (the<br \/>\n&#8220;Securities&#8221;) of the Company&#8217;s Class A common stock, par value $.01 per share<br \/>\n(the &#8220;Common Stock&#8221;). In recognition of the benefit that such an offering will<br \/>\nconfer upon the undersigned as a stockholder, officer or director of the<br \/>\nCompany, and for other good and valuable consideration, the receipt and<br \/>\nsufficiency of which are hereby acknowledged, the undersigned agrees with each<br \/>\nunderwriter to be named in the Purchase Agreement that, during a period of 90<br \/>\ndays from the date of the Purchase Agreement, the undersigned will not, without<br \/>\nthe prior written consent of Merrill Lynch, directly or<\/p>\n<p>                                      B-1<br \/>\n   64<br \/>\nindirectly, (i) offer, pledge, sell, contract to sell, sell any option or<br \/>\ncontract to purchase, purchase any option or contract to sell, grant any option,<br \/>\nright or warrant for the sale of, or otherwise dispose of or transfer any shares<br \/>\nof the Company&#8217;s Common Stock or any securities convertible into or exchangeable<br \/>\nor exercisable for Common Stock, whether now owned or hereafter acquired by the<br \/>\nundersigned or with respect to which the undersigned has or hereafter acquires<br \/>\nthe power of disposition, or file any registration statement under the<br \/>\nSecurities Act of 1933, as amended , with respect to any of the foregoing or<br \/>\n(ii) enter into any swap or any other agreement or any transaction that<br \/>\ntransfers, in whole or in part, directly or indirectly, the economic consequence<br \/>\nof ownership of the Common Stock, whether any such swap or transaction is to be<br \/>\nsettled by delivery of Common Stock or other securities, in cash or otherwise.<br \/>\n[The foregoing restriction will not apply to Securities to be sold by the<br \/>\nSelling Shareholders under the Purchase Agreement.](1)<\/p>\n<p>         Notwithstanding the foregoing restrictions on transfer, the undersigned<br \/>\nshall be permitted to make the following transfers: (i) transfers made by gift,<br \/>\nwill or intestacy, provided the donee thereof agrees in writing to be bound by<br \/>\nthe terms hereof; (ii) transfers to the transferor&#8217;s affiliates, as such term is<br \/>\ndefined in Rule 405 promulgated under the Securities Act, provided that each<br \/>\ntransferee agrees in writing to be bound by the terms hereof; (iii) transfers<br \/>\nmade with prior written consent of Merrill Lynch; and (iv) in the event the<br \/>\nundersigned is an individual, transfers to his or her immediate family or to a<br \/>\ntrust the beneficiaries of which are exclusively the undersigned or a member or<br \/>\nmembers of his or her immediate family, provided that any transferee agrees in<br \/>\nwriting to be bound by the terms hereof.<\/p>\n<p>                         Very truly yours,<\/p>\n<p>                         [Name of company, corporation, partnership or trust](2)<\/p>\n<p>                         By:<br \/>\n                            &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                            Name:<\/p>\n<p>                         [Title:]<\/p>\n<p>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n(1) To be included in the lock-up agreements to be signed by the Selling<br \/>\n    Shareholders.<br \/>\n(2) Does not apply to individual shareholders.<\/p>\n<p>                                      B-2<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6846,7234,7412],"corporate_contracts_industries":[9415,9418],"corporate_contracts_types":[9622,9627],"class_list":["post-43345","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-bank-of-america-corp","corporate_contracts_companies-credit-suisse-first-boston-inc","corporate_contracts_companies-edison-schools-inc","corporate_contracts_industries-financial__banks","corporate_contracts_industries-financial__securities","corporate_contracts_types-planning","corporate_contracts_types-planning__purchase"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43345"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43345"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43345"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}